At AssayQuant, we understand that every project is unique. Reach out today to schedule your complimentary consultation and let us help you find the perfect fit for your needs.
HGNC (Common) Name | Coral Name | Ser(S)/Thr(T) or Tyr(Y) | Family | Wild-Type or Mutant | HGNC Approved Full Name | Consolidated Aliases |
---|---|---|---|---|---|---|
AAK1 | AAK1 | S/T | NAK | Wild-Type | AP2 associated kinase 1 | AAK1; KIAA1048; Adaptor-associated kinase 1; AP2 associated kinase 1 |
ABL1 | ABL1 | Y | ABL | Wild-Type | ABL proto-oncogene 1, non-receptor tyrosine kinase | ABL; ABL1; JTK7; c-ABL; C-ABL; v-abl; p150; BCR-ABL; Abelson murine leukemia viral oncogene 1; V-abl Abelson murine leukemia viral oncogene 1 |
ABL2 (ARG) | ABL2 | Y | ABL | Wild-Type | ABL proto-oncogene 2, non-receptor tyrosine kinase | ABL2; ARG; ABLL; Abelson-related gene |
AKT1 (PKB) | AKT1 | S/T | AKT | Wild-Type | AKT Serine/Threonine Kinase 1 | AKT1; AKT Serine/Threonine Kinase 1; RAC- ALPHA; AKT; PKB; PRKBA; RAC; PKB; PKB-alpha; V-akt murine thymoma viral oncogene 1; Protein kinase B; RAC; RAC-PK-alpha; C-AKT |
AKT2 (PKBb) | AKT2 | S/T | AKT | Wild-Type | AKT Serine/Threonine Kinase 2 | AKT2; AKT Serine/Threonine Kinase 2; PRKBB; PKBBETA; RAC- BETA; PKB beta; RAC-PK-beta |
AKT3 (PKBg) | AKT3 | S/T | AKT | Wild-Type | AKT Serine/Threonine Kinase 3 | AKT3; AKT Serine/Threonine Kinase 3; PKBG; PRKBG; STK-2; RAC-gamma; RAC-PK- gamma |
ALK | ALK | Y | ALK | Wild-Type | ALK receptor tyrosine kinase | ALK; ALK receptor tyrosine kinase; Anaplastic lymphoma kinase; Anaplastic lymphoma kinase (Ki-1); Anaplastic lymphoma receptor tyrosine kinase; CD246; ALK tyrosine kinase receptor |
PRKAA1-B1-G1 (AMPKα1β1γ1) | AMPKa1 | S/T | CAMKL | Wild-Type | Protein kinase AMP-activated catalytic subunit alpha 1 | PRKAA1; AMPKa1; Protein kinase AMP-activated catalytic subunit alpha 1; MGC33776; MGC57364; AMPK alpha 1; 5'-AMP-activated protein kinase, catalytic alpha-1 chain; AAPK1 |
PRKAA1-B1-G2 (AMPKα1β1γ2) | AMPKa1 | S/T | CAMKL | Wild-Type | PRKAA1; AMPKa1; Protein kinase AMP-activated catalytic subunit alpha 1; MGC33776; MGC57364; AMPK alpha 1; 5'-AMP-activated protein kinase, catalytic alpha-1 chain; AAPK1 | Protein-serine/threonine kinase |
PRKAA1-B1-G3 (AMPKα1β1γ3) | AMPKa1 | S/T | CAMKL | Wild-Type | PRKAA1; AMPKa1; Protein kinase AMP-activated catalytic subunit alpha 1; MGC33776; MGC57364; AMPK alpha 1; 5'-AMP-activated protein kinase, catalytic alpha-1 chain; AAPK1 | Protein-serine/threonine kinase |
PRKAA1-B2-G1 (AMPKα1β2γ1) | AMPKa1 | S/T | CAMKL | Wild-Type | Protein kinase AMP-activated catalytic subunit alpha 1 | PRKAA1; AMPKa1; Protein kinase AMP-activated catalytic subunit alpha 1; MGC33776; MGC57364; AMPK alpha 1; 5'-AMP-activated protein kinase, catalytic alpha-1 chain; AAPK1 |
PRKAA1-B2-G2 (AMPKα1β2γ2) | AMPKa1 | S/T | CAMKL | Wild-Type | PRKAA1; AMPKa1; Protein kinase AMP-activated catalytic subunit alpha 1; MGC33776; MGC57364; AMPK alpha 1; 5'-AMP-activated protein kinase, catalytic alpha-1 chain; AAPK1 | Protein-serine/threonine kinase |
PRKAA1-B2-G3 (AMPKα1β2γ3) | AMPKa1 | S/T | CAMKL | Wild-Type | PRKAA1; AMPKa1; Protein kinase AMP-activated catalytic subunit alpha 1; MGC33776; MGC57364; AMPK alpha 1; 5'-AMP-activated protein kinase, catalytic alpha-1 chain; AAPK1 | Protein-serine/threonine kinase |
PRKAA2-B1-G1 (AMPKα2β1γ1) | AMPKa2 | S/T | CAMKL | Wild-Type | Protein kinase AMP-activated catalytic subunit alpha 2 | PRKAA2; AMPKa2; protein kinase AMP-activated catalytic subunit alpha 2; AMPK; AMPK2; PRKAA; AAPK2; AMPK alpha-2 chain; |
PRKAA2-B1-G2 (AMPKα2β1γ2) | AMPKa2 | S/T | CAMKL | Wild-Type | Protein-serine/threonine kinase | nan |
PRKAA2-B1-G3 (AMPKα2β1γ3) | AMPKa2 | S/T | CAMKL | Wild-Type | Protein-serine/threonine kinase | nan |
PRKAA2-B2-G1 (AMPKα2β2γ1) | AMPKa2 | S/T | CAMKL | Wild-Type | Protein kinase AMP-activated catalytic subunit alpha 2 | PRKAA2; AMPKa2; protein kinase AMP-activated catalytic subunit alpha 2; AMPK; AMPK2; PRKAA; AAPK2; AMPK alpha-2 chain; |
PRKAA2-B2-G2 (AMPKα2β2γ2) | AMPKa2 | S/T | CAMKL | Wild-Type | PRKAA2; AMPKa2; protein kinase AMP-activated catalytic subunit alpha 2; AMPK; AMPK2; PRKAA; AAPK2; AMPK alpha-2 chain; | Protein-serine/threonine kinase |
PRKAA2-B2-G3 (AMPKα2β2γ3) | AMPKa2 | S/T | CAMKL | Wild-Type | PRKAA2; AMPKa2; protein kinase AMP-activated catalytic subunit alpha 2; AMPK; AMPK2; PRKAA; AAPK2; AMPK alpha-2 chain; | Protein-serine/threonine kinase |
AURKA (AURA) | AurA | S/T | AUR | Wild-Type | Aurora kinase A | AURKA; AurA; aurora kinase A; Aurora-A kinase; PPP1R47; protein phosphatase 1, regulatory subunit 47; AIK; ARK1; BTAK; STK15; MGC34538; STK6; Aurora-A; STK7; IPL1-related kinase 1; Aurora-1; Aurora-family kinase 1 |
AURKB (AURB) | AurB | S/T | AUR | Wild-Type | Aurora kinase B | AURKB; AurB; aurora kinase B; aurora-1; aurora-B; IPL1; PPP1R48; protein phosphatase 1, regulatory subunit 48; AIK2; AIM1; ARK2; STK5; AIM-1; STK12; IPL1-related kinase 2; Aurora-2; Aurora-B |
AURKC (AURC) | AurC | S/T | AUR | Wild-Type | Aurora kinase C | AURKC; AurC; aurora kinase C; ARK3, AurC; AIE2; AIK3; STK13; AIE1; Ipl1-related kinase 3; Aurora-C; STKD |
AXL | AXL | Y | Axl | Wild-Type | AXL receptor tyrosine kinase | AXL; AXL receptor tyrosine kinase; Tyro7; EC; UFO; ARK; JTK11; UF; Adhesion-related kinase |
BCKDK | BCKDK | S/T | PDHK | Wild-Type | branched chain ketoacid dehydrogenase kinase | BCKDK; branched chain ketoacid dehydrogenase kinase; BCKD; BCKDHKIN |
BCR RET (fusion) | RET | Y | nan | Mutant | nan | nan |
BMP2K (BIKE) | BIKE | S/T | NAK | Wild-Type | BMP2 inducible kinase | BMP2K; BIKE; BMP2 inducible kinase; BM2K; DKFZp434K0614; DKFZp434P0116; HRIHFB2017 |
BLK | BLK | Y | Src | Wild-Type | BLK proto-oncogene, Src family tyrosine kinase | BLK; BLK proto-oncogene, Src family tyrosine kinase; MGC10442; B lymphoid tyrosine kinase; B lymphocyte kinase; P55-BLK |
BMX | BMX | Y | Tec | Wild-Type | BMX non-receptor tyrosine kinase | BMX; BMX non-receptor tyrosine kinase; BTK-like on X chromosome; ETK; PSCTK2; PSCTK3; Bone marrow kinase BMX; NTK38; Epithelial and endothelial tyrosine kinase |
BRAF (BRAF1, RAFB1) | BRAF | S/T | RAF | Wild-Type | BRAF; B-Raf proto-oncogene, serine/threonine kinase; v-raf murine sarcoma viral oncogene homolog B; B-Raf; B-raf-1; RAFB1; RMIL; C-RMIL; | Protein-serine/threonine kinase |
BRAF, b-[V600E] | BRAF | S/T | RAF | Mutant | B-Raf proto-oncogene, serine/threonine kinase | BRAF; B-Raf proto-oncogene, serine/threonine kinase; v-raf murine sarcoma viral oncogene homolog B; B-Raf; B-raf-1; RAFB1; RMIL; C-RMIL; |
BRSK1 | BRSK1 | S/T | CAMKL | Wild-Type | BR serine/threonine kinase 1 | BRSK1; BR serine/threonine kinase 1; KIAA1811; SAD1; SAD1A |
BRSK2 | BRSK2 | S/T | CAMKL | Wild-Type | BR serine/threonine kinase 2 | BRSK2; BR serine/threonine kinase 2; chromsosome 11 open reading frame 7; C11orf7; PEN11B; SAD1; STK29; SAD1B |
BTK | BTK | Y | TEK | Wild-Type | Bruton tyrosine kinase | BTK; Bruton tyrosine kinase; IMD1; AGMX1; AT; BPK; PSCTK1; ATK; Bruton's tyrosine kinase; XLA; Agammaglobulinaemia tyrosine kinase; B cell progenitor kinase; BPK |
BUB1 | BUB1 | S/T | BUB | Wild-Type | BUB1 mitotic checkpoint serine/threonine kinase | BUB1; BUB1 mitotic checkpoint serine/threonine kinase; budding uninhibited by benzimidazoles 1; BUB1A; BUB1L; hBUB1; Mitotic checkpoint BUB1; MBUB1 |
BUB1B (BUBR1) | BUBR1 | S/T | BUB | Wild-Type | BUB1 mitotic checkpoint serine/threonine kinase B | BUBR1; MAD3L; Bub1A; SSK1; budding uninhibited by benzimidazoles 1 (yeast homolog), beta; budding uninhibited by benzimidazoles 1 homolog beta (yeast) |
CAMK1 (CAMK1a) | CaMK1a | S/T | CAMK1 | Wild-Type | Calcium/calmodulin dependent protein kinase I | CAMK1; CaMK1a; calcium/calmodulin dependent protein kinase I; CAMK1-PEN; CAMKIa; KCC1; KCC1A; CAM kinase I; CaMK1-alpha; CaMKI |
PNCK (CAMK1β) | CaMK1b | S/T | CAMK1 | Wild-Type | Pregnancy up-regulated nonubiquitous CaM kinase | PNCK; CaMK1b; pregnancy up-regulated nonubiquitous CaM kinase; MGC45419; CaM kinase I beta; KCC1B; CaMK1-beta |
CAMK1D (CAMK1δ) | CaMK1d | S/T | CAMK1 | Wild-Type | Calcium/calmodulin dependent protein kinase ID | CAMK1D; CaMK1d; calcium/calmodulin dependent protein kinase ID; CKLiK; CaM-K1; CaMK1-delta; CaM-KI delta; KCC1D |
CAMK1G (CAMK1γ) | CaMK1g | S/T | CAMK1 | Wild-Type | Calcium/calmodulin dependent protein kinase IG | CAMK1G; CaMK1g; calcium/calmodulin dependent protein kinase IG; CLICKIII; VWS1; dJ272L16.1; Calcium/calmodulin-dependent protein kinase I gamma; KCC1G; VWS1; CaMK1-gamma; CaMK-like CREB kinase III |
CAMK2A (CAMK2α) | CaMK2a | S/T | CAMK2 | Wild-Type | Calcium/calmodulin dependent protein kinase II alpha | CAMK2A; calcium/calmodulin dependent protein kinase II alpha; CaM kinase II alpha subunit; CaMKIINalpha; CAMKA; KIAA0968; CAMK2a; CaMKII-alpha; CaMKIINalpha; KCC2A; CaMK2-alpha |
CAMK2B (CAMK2β) | CaMK2b | S/T | CAMK2 | Wild-Type | Calcium/calmodulin dependent protein kinase II beta | CAMK2B; CaMK2b; calcium/calmodulin dependent protein kinase II beta; CaM kinase II beta; CaM-kinase II beta chain; CAM; CAMK2; CAMK2b; CAM2; CAMK2; CAMKB; MGC29528; CaMK-II beta; KCC2B;CaMK2-beta |
CAMK2D (CAMK2δ) | CaMK2d | S/T | CAMK2 | Wild-Type | Calcium/calmodulin dependent protein kinase II delta | CAMK2D; CaMK2d; calcium/calmodulin dependent protein kinase II delta; CAMK2d; CAMKD; MGC44911; CaMKII delta; CaM-kinase II delta; KCC2D; KCCD |
CAMK2G (CAMK2γ) | CaMK2g | S/T | CAMK2 | Wild-Type | Calcium/calmodulin dependent protein kinase II gamma | CAMK2G; CaMK2g; calcium/calmodulin dependent protein kinase II gamma; CAMK; CAMK-II; CAMKG; MGC26678; CaM-kinase II gamma; CaMK2-gamma; CaMK-II gamma |
CAMK4 | CaMK4 | S/T | CAMK1 | Wild-Type | Calcium/calmodulin dependent protein kinase IV | CAMK4; calcium/calmodulin dependent protein kinase IV; brain Ca++-calmodulin-dependent protein kinase type IV; CAM kinase IV; CaMK-GR; MGC36771; CAM kinase-GR; CaMK IV; KCC4; Calspermin |
CAMKK1 | CaMKK1 | S/T | CAMKK | Wild-Type | Calcium/calmodulin dependent protein kinase kinase 1 | CAMKK1; calcium/calmodulin dependent protein kinase kinase 1; CAMKKA; DKFZp761M0423; MGC34095; KKCC1; CaMKK alpha |
CAMKK2 | CaMKK2 | S/T | CAMKK | Wild-Type | Calcium/calmodulin dependent protein kinase kinase 2 | CAMKK2; calcium/calmodulin dependent protein kinase kinase 2; calcium/calmodulin-dependent protein kinase kinase beta; CAMKK; CAMKKB; KIAA0787; MGC15254; Calcium/calmodulin-dependent protein kinase; KKCC2; CaM-kinase kinase beta; CaMKK beta |
CDC7/DBF4 (CDC7) | CDC7 | S/T | CDC7 | Wild-Type | Cell division cycle 7 | CDC7/DBF4; CDC7; cell division cycle 7; CDC7L1; HsCDC7; Hsk1; huCDC7; Cell division cycle 7-related protein kinase; CDC7- related kinase |
CDK1 (CDC2)/CycA1 | CDC2 | S/T | CDK | Wild-Type | CDK1; CDC2; cyclin dependent kinase 1; CDC28; CDC28A; MPF; CDC2A; Cell division control protein 2 | Protein-serine/threonine kinase |
CDK1 (CDC2)/CycA2 | CDC2 | S/T | CDK | Wild-Type | Cyclin dependent kinase 1 | CDK1; CDC2; cyclin dependent kinase 1; CDC28; CDC28A; MPF; CDC2A; Cell division control protein 2 |
CDK1 (CDC2)/CycB1 | CDC2 | S/T | CDK | Wild-Type | Cyclin dependent kinase 1 | CDK1; CDC2; cyclin dependent kinase 1; CDC28; CDC28A; MPF; CDC2A; Cell division control protein 2 |
CDK1 (CDC2)/CycE1 | CDC2 | S/T | CDK | Wild-Type | Cyclin dependent kinase 1 | CDK1; CDC2; cyclin dependent kinase 1; CDC28; CDC28A; MPF; CDC2A; Cell division control protein 2 |
CDK19 (CDK11)/CycC | CDK11 | S/T | CDK | Wild-Type | Cyclin dependent kinase 19 | CDK11; CDC2L6; KIAA1028; bA346C16.3 |
CDK12 (CRK7)/CycK | CRK7 | S/T | CDK | Wild-Type | Cyclin dependent kinase 12 | CDK12; CRK7; cyclin dependent kinase 12; CDC2 related protein kinase 7; CRKR; KIAA0904; CRKRS; CD2L7; CDC2 related protein kinase 7 |
CDK13 (CHED)/CycK | CHED | S/T | CDK | Wild-Type | Cyclin dependent kinase 13 | CDK13; CHED; cyclin dependent kinase 13; cholinesterase-related cell division controller; cell division cycle 2-like 5; CDC2L; CDC2L5; KIAA1791; CD2L5; CDC2-related protein kinase 5; Cell division cycle 2-like 5 |
CDK14 (PFTAIRE1, PFTK1)/CycY | PFTAIRE1 | S/T | CDK | Wild-Type | Cyclin dependent kinase 14 | CDK14; PFTAIRE1; cyclin dependent kinase 14; PFTK1; KIAA0834; PFT1; PFTAIRE protein kinase 1 |
CDK15 (PFTAIRE2, PFTK2)/CycB1 | PFTAIRE2 | S/T | CDK | Wild-Type | Cyclin dependent kinase 15 | CDK15; PFTAIRE2; cyclin dependent kinase 15; PFTK2; ALS2CR7; A2S7; AL2S7; Amyotrophic lateral sclerosis 2 chromosomal region candidate gene protein 7 |
CDK16 (PCTAIRE1, PCTK1)/CycY | PCTAIRE1 | S/T | CDK | Wild-Type | Cyclin dependent kinase 16 | CDK16; PCTAIRE1; cyclin dependent kinase 16; FLJ16665; PCTGAIRE; PCTK1; PCTGAIRE; KPT1 |
CDK17 (PCTAIRE2, PCTK2)/CycY | PCTAIRE2 | S/T | CDK | Wild-Type | Cyclin dependent kinase 17 | CDK17; PCTAIRE2; cyclin dependent kinase 17; PCTK2; KPT2 |
CDK17 (PCTAIRE2, PCTK2)/p35NCK | PCTAIRE2 | S/T | CDK | Wild-Type | CDK17; PCTAIRE2; cyclin dependent kinase 17; PCTK2; KPT2 | Protein-serine/threonine kinase |
CDK18 (PCTAIRE3, PCTK3)/CycY | PCTAIRE3 | S/T | CDK | Wild-Type | Cyclin dependent kinase 18 | CDK18; PCTAIRE3; cyclin dependent kinase 18; PCTK3; KPT3 |
CDK2/CycA1 | CDK2 | S/T | CDK | Wild-Type | Cyclin dependent kinase 2 | CDK2; CDK2; cyclin dependent kinase 2; p33 (CDK2) |
CDK2/CycA2 | CDK2 | S/T | CDK | Wild-Type | Cyclin dependent kinase 2 | CDK2; CDK2; cyclin dependent kinase 2; p33 (CDK2) |
CDK2/CycE1 | CDK2 | S/T | CDK | Wild-Type | Cyclin dependent kinase 2 | CDK2; CDK2; cyclin dependent kinase 2; p33 (CDK2) |
CDK2/CycE2 | CDK2 | S/T | CDK | Wild-Type | Cyclin dependent kinase 2 | CDK2; CDK2; cyclin dependent kinase 2; p33 (CDK2) |
CDK2/CycO | CDK2 | S/T | nan | Wild-Type | nan | nan |
CDK3/CycE1 | CDK3 | S/T | CDK | Wild-Type | Cyclin dependent kinase 3 | CDK3; cyclin dependent kinase 3; CDKN3 |
CDK3/CycE2 | CDK3 | S/T | CDK | Wild-Type | Cyclin dependent kinase 3 | CDK3; cyclin dependent kinase 3; CDKN3 |
CDK4/CycD1 | CDK4 | S/T | CDK | Wild-Type | Cyclin dependent kinase 4 | CMGC |
CDK4/CycD2 | CDK4 | S/T | CDK | Wild-Type | Cyclin dependent kinase 4 | CMGC |
CDK4 /CycD3 | CDK4 | S/T | CDK | Wild-Type | Cyclin dependent kinase 4 | CDK4; cyclin dependent kinase 4; CMM3; PSK-J3; MGC14458; CRK3 |
CDK5/p25 | CDK5 | S/T | CDK | Wild-Type | Cyclin dependent kinase 5 | CDK5; cyclin dependent kinase 5; PSSALRE; CRK6; TPKII; TAU protein kinase II |
CDK5/p35NCK | CDK5 | S/T | CDK | Wild-Type | Cyclin dependent kinase 5 | CDK5; cyclin dependent kinase 5; PSSALRE; CRK6; TPKII; TAU protein kinase II |
CDK6/CycD1 | CDK6 | S/T | CDK | Wild-Type | Cyclin dependent kinase 6 | CDK6; cyclin dependent kinase 6; PLSTIRE; CRK2 |
CDK6/CycD2 | CDK6 | S/T | CDK | Wild-Type | Cyclin dependent kinase 6 | nan |
CDK6/CycD3 | CDK6 | S/T | CDK | Wild-Type | Cyclin dependent kinase 6 | CDK6; cyclin dependent kinase 6; PLSTIRE; CRK2 |
CDK7/CycH/MAT1 | CDK7 | S/T | CDK | Wild-Type | Cyclin dependent kinase 7 | CDK7; cyclin dependent kinase 7; CAK; MO15; CAK1; CDKN7; STK1; p39MO15; CRK4; CDK-activating kinase; CR4 protein kinase |
CDK7/CycH1 | CDK7 | S/T | CDK | Wild-Type | Cyclin dependent kinase 6 | CDK7; cyclin dependent kinase 7; CAK; MO15; CAK1; CDKN7; STK1; p39MO15; CRK4; CDK-activating kinase; CR4 protein kinase |
CDK9 (TAK)/CycK | CDK9 | S/T | CDK | Wild-Type | Cyclin dependent kinase 9 | CDK9; cyclin dependent kinase 9; C-2k; PITALRE; TAK; CDC2L4; CDK9/CycK; Cell division cycle 2-like protein kinase 4 |
CDK9 (TAK)/CycT1 | CDK9 | S/T | CDK | Wild-Type | Cyclin dependent kinase 9 | CDK9; cyclin dependent kinase 9; C-2k; PITALRE; TAK; CDC2L4; CDK9/CycK; Cell division cycle 2-like protein kinase 4 |
CDK9 (TAK)/CycT2 | CDK9 | S/T | CDK | Wild-Type | Cyclin dependent kinase 9 | CDK9; cyclin dependent kinase 9; C-2k; PITALRE; TAK; CDC2L4; CDK9/CycK; Cell division cycle 2-like protein kinase 4 |
CDKL5 | CDKL5 | S/T | nan | Wild-Type | Protein-serine/threonine kinase | CMGC |
TRPM7 (CHAK1) | ChaK1 | S/T | ALPHA | Wild-Type | Channel-kinase 1 | CHAK1; Channel-kinase 1 |
CHEK1 (CHK1) | CHK1 | S/T | CAMKL | Wild-Type | Check point kinase 1 | CHEK1; CHK1; Check point kinase 1 |
CHEK2 (CHK2) | CHK2 | S/T | RAD53 | Wild-Type | Check point kinase 2 | CHEK2; CHK2; Check point kinase 2; CDS1; CHK2; HuCds1; PP1425; RAD53; bA444G7 |
CSNK1A1 (CK1A1, CK1α) | CK1a | S/T | CK1 | Wild-Type | Casein kinase 1 alpha 1 | CSNK1A1; CK1a; casein kinase 1 alpha 1; CK1; CK1alpha; CKIa, CKIalpha; clock regulator kinase; CK1; HLCDGP1; PRO2975; KC1A |
CSNK1A1L (CK1A1L, CK1a2) | CK1a2 | S/T | CK1 | Wild-Type | Casein kinase 1 alpha 1 like | CSNK1A1L; CK1a2; casein kinase 1 alpha 1 like; MGC33182; CK1-alpha2; CK1; KC1AL; CKI-alpha; CSNK1A2 |
CSNK1D (CK1D, CK1δ) | CK1d | S/T | CK1 | Wild-Type | Casein kinase 1 delta | CSNK1D; CK1d; casein kinase 1 delta; CKID, CKIdelta; HCKID; CK1d; CK1-delta; KC1D; CSNK1D |
CSNK1E (CK1E, CK1ε) | CK1e | S/T | CK1 | Wild-Type | Casein kinase 1 epsilon | CSNK1E; CK1e; casein kinase 1 epsilon; CKIE; CKIepsilon; HCKIE; MGC10398; KC1E |
CSNK1G1 (CK1G1, CK1γ1) | CK1g1 | S/T | CK1 | Wild-Type | Casein kinase 1 gamma 1 | CSNK1G1; CK1g1; casein kinase 1 gamma 1; CK1-gamma1; KC11; KC1G1 |
CSNK1G2 (CK1G2, CK1γ2) | CK1g2 | S/T | CK1 | Wild-Type | Casein kinase 1 gamma 2 | CSNK1G2; CK1g2; casein kinase 1 gamma 2; CK1-gamma2; KC12; KC1G2 |
CSNK1G3 (CK1G3, CK1γ3) | CK1g3 | S/T | CK1 | Wild-Type | Casein kinase 1 gamma 3 | CSNK1G3; CK1g3; casein kinase 1 gamma 3; CK1-gamma3; KC13; KC1G3 |
CSNK2A1 (CK2A1, CK2α1) | CK2a1 | S/T | CK2 | Wild-Type | Casein kinase 2 alpha 1 | CSNK2A1; CK2a1; casein kinase 2 alpha 1; Cka1, Cka2; CSNK2A1; CKII; CK2A1; CK2-alpha1; Casein kinase II, alpha chain; CKIIA; CSK21 |
CSNK2A2 (CK2A2, CK2α2) | CK2a2 | S/T | CK2 | Wild-Type | Casein kinase 2 alpha 2 | CSNK2A2; CK2a2; casein kinase 2 alpha 2; CK2alpha; CSNK2A1; CK2-alpha2; CK II; CK2A2; CSK22 |
CLK1 | CLK1 | S/T | CLK | Wild-Type | CDC like kinase 1 | CLK1; CDC like kinase 1; CLK; CLK/STY |
CLK2 | CLK2 | S/T | CLK | Wild-Type | CDC like kinase 2 | CLK2; CDC like kinase 2; MGC6150 |
CLK3 | CLK3 | S/T | CLK | Wild-Type | CDC like kinase 3 | CLK3; CDC like kinase 3; FLJ22858; PHCLK3; PHCLK3/152 |
CLK4 | CLK4 | S/T | CLK | Wild-Type | CDC like kinase 4 | CLK4; CDC like kinase 4; DKFZp686A20267 |
CIT (CRIK) | CRIK | S/T | DMPK | Wild-Type | Citron rho-interacting serine/threonine kinase | CIT; CRIK; citron rho-interacting serine/threonine kinase; CITK; STK2; STK21; KIAA0949; Citron; Rho-interacting, serine/threonine kinase 21; CTRO; KIAA0949 |
CSK | CSK | Y | Csk | Wild-Type | C-terminal Src kinase | CSK; C-terminal Src kinase; CYL; MGC117393; MPK-2 |
MATK (CTK) | CTK | Y | Csk | Wild-Type | Megakaryocyte-associated tyrosine-protein kinase | MATK; CTK; megakaryocyte-associated tyrosine kinase; Csk-homologous kinase; DKFZp434N1212 HHYLTK; hematopoietic consensus tyrosine-lacking kinase; HYL; hydroxyaryl-protein kinase; leukocyte carboxyl-terminal src kinase related; MGC1708; MGC2101; MATK |
DAPK1 | DAPK1 | S/T | DAPK | Wild-Type | Death-associated protein kinase 1 | DAPK1; Death-associated protein kinase 1; DAPK, ROCO3; DKFZp781I035 |
DAPK2 (DRP-1) | DAPK2 | S/T | DAPK | Wild-Type | Death-associated protein kinase 2 | DAPK2; Death-associated protein kinase 2; DRP-1; MGC119312; DAP-kinase related protein 1 |
DAPK3 (ZIPK) | DAPK3 | S/T | DAPK | Wild-Type | Death-associated protein kinase 3 | DAPK3; Death-associated protein kinase 3; ZIP; ZIPK; DAP kinase 3; Dlk; FLJ36473 |
DCLK1 (DCAMKL1) | DCAMKL1 | S/T | DCAMKL | Wild-Type | Doublecortin like kinase 1 | DCLK1; DCAMKL1; doublecortin like kinase 1; DCDC3A; DCLK; KIAA0369; DCAK1 |
DCLK2 (DCAMKL2) | DCAMKL2 | S/T | DCAMKL | Wild-Type | Doublecortin like kinase 2 | DCLK2; DCAMKL2; doublecortin like kinase 2; DCDC3; DCDC3B; DCK2; DKFZp761I032; MGC45428; DCAK2 |
DDR1 [SRC treated] | DDR1 | Y | nan | Wild-Type | Discoidin domain receptor tyrosine kinase 1 | DDR1; discoidin domain receptor tyrosine kinase 1; CAK; CD167; DDR; EDDR1; MCK10; NEP; NTRK4; PTK3; PTK3A; RTK6; TRKE; Discoidin receptor tyrosine kinase |
DDR2 | DDR2 | Y | DDR | Wild-Type | Discoidin domain receptor tyrosine kinase 2 | DDR2; discoidin domain receptor tyrosine kinase 2; TKT; NTRKR3; TYRO10; CAK; CD167; DDR; EDDR1; MCK10; NEP; NTRK4; PTK3; PTK3A; RTK6; TRKE; Discoidin domain receptor 2; Neurotrophic tyrosine kinase, receptor-related 3 |
DMPK (DMPK1) | DMPK1 | S/T | nan | Wild-Type | DM1 protein kinase | DMPK; DMPK1; DM1 protein kinase; dystrophia myotonica 1; MDPK; MT-PK; myotonic dystrophy associated protein kinase; myotonin protein kinase A; thymopoietin homolog; DM; DM1; DM1PK; DMK |
CDC42BPG (DMPK2) | DMPK2 | S/T | DMPK | Wild-Type | CDC42 binding protein kinase gamma | CDC42BPG; DMPK2; CDC42 binding protein kinase gamma; HSMDPKIN; KAPPA-200; MRCKgamma; MRCKG; Myotonic dystrophy protein kinase like protein |
PRKDC (DNA-PK) | DNAPK | S/T | PIKK | Wild-Type | Protein kinase, DNA-activated, catalytic polypeptide | PRKDC; DNAPK; protein kinase, DNA-activated, catalytic polypeptide; DNA-dependent protein kinase; DNA-PKcs; DNPK1; HYRC; HYRC1; XRCC7; p350; P460; PRKD |
STK17A (DRAK1) | DRAK1 | S/T | DAPK | Wild-Type | Serine/threonine kinase 17a | STK17A; DRAK1; Serine/threonine kinase 17a; Death-associated protein kinase-related 1; ST17A |
STK17B (DRAK2) | DRAK2 | S/T | DAPK | Wild-Type | Serine/threonine kinase 17b | STK17B; DRAK2; Serine/threonine kinase 17b; Death-associated protein kinase-related 2; ST17B |
DYRK1A | DYRK1A | S/T | DYRK | Wild-Type | Dual specificity tyrosine phosphorylation regulated kinase 1A | DYRK1A; dual specificity tyrosine phosphorylation regulated kinase 1A; DYRK; DYRK1; HP86; MNB; MNBH; DYR1A |
DYRK1B | DYRK1B | S/T | DYRK | Wild-Type | Dual specificity tyrosine phosphorylation regulated kinase 1B | DYRK1B; dual specificity tyrosine phosphorylation regulated kinase 1B; minibrain-related kinase; MIRK; DYR1B |
DYRK2 | DYRK2 | S/T | DYRK | Wild-Type | Dual specificity tyrosine phosphorylation regulated kinase 2 | DYRK2; dual specificity tyrosine phosphorylation regulated kinase 2 |
DYRK3 | DYRK3 | S/T | DYRK | Wild-Type | Dual specificity tyrosine phosphorylation regulated kinase 3 | DYRK3; dual specificity tyrosine phosphorylation regulated kinase 3; RED; REDK; regulatory erythroid kinase; DYRK5; dual-specificity tyrosine phosphorylation regulated kinase 5 |
DYRK4 | DYRK4 | S/T | DYRK | Wild-Type | Dual specificity tyrosine phosphorylation regulated kinase 4 | DYRK4; dual specificity tyrosine phosphorylation regulated kinase 4 |
EEF2K (eEF2K) | eEF2K | S/T | Alpha | Wild-Type | Eukaryotic elongation factor 2 kinase | EEF2K; eukaryotic elongation factor 2 kinase; HSU93850; MGC45041; eEF- 2K; Calcium/calmodulin-dependent eukaryotic elongation factor 2 kinase; EEF-2 kinase; Elongation factor 2 kinase |
EGFR (ERBB1) | EGFR | Y | EGFR | Wild-Type | Epidermal growth factor receptor | EGFR; Epidermal growth factor receptor; erb-b2 receptor tyrosine kinase 1; ERBB; ERBB1; mENA; HER1; erythroblastic leukemia viral (v-erb-b) oncogene homolog (avian); avian erythroblastic leukemia viral (v-erb-b) oncogene homolog; Receptor tyrosine-protein kinase ErbB-1; V-erb-b oncogene homologue |
EPHA1 | EphA1 | Y | Eph | Wild-Type | EPH receptor A1 | EPHA1; EphA1; EPH receptor A1; EPH; EPHT; EPHT1; EEPHT1; ephrin type-A receptor 1; MGC163163; EPH receptor A1 |
EPHA2 | EphA2 | Y | Eph | Wild-Type | EPH receptor A2 | EPHA2; EphA2; EPH receptor A2; ECK; SEK2; MPK-5; ephrin type-A receptor 2; SEK-2; Epithelial cell kinase |
EPHA3 | EphA3 | Y | Eph | Wild-Type | EPH receptor A3 | EPHA3; EphA3; EPH receptor A3; ETK; ETK1; EphA3; HEKECK; HEK; HEK4; TYRO4; ephrin type-A receptor 3; EPA3; REK4 |
EPHA4 | EphA4 | Y | Eph | Wild-Type | EPH receptor A4 | EPHA4; EphA4; EPH receptor A4; HEK8; SEK; TYRO1; ephrin type-A receptor 4 |
EPHA5 | EphA5 | Y | Eph | Wild-Type | EPH receptor A5 | EPHA5; EphA5; EPH receptor A5; CEK7; EHK1; EphA5; HEK7; HGNC:12448; TYRO4; Hek7; ephrin type-A receptor 5; Eph homology kinase-1; EHK-1 |
EPHA6 | EphA6 | Y | Eph | Wild-Type | EPH receptor A6 | EPHA6; EphA6; EPH receptor A6; EHK2; FLJ35246; ephrin receptor EphA6; DKFZp434C1418; PRO57066; EHK-2; EPH homology kinase 2; Ephrin type-A receptor 6 |
EPHA7 | EphA7 | Y | Eph | Wild-Type | EPH receptor A7 | EPHA7; EphA7; EPH receptor A7; EHK3; HEK11; EK11; EPA7; ephrin type-A receptor 7; Developmental kinase 1; EBK; EPH homology kinase-3; EHK-3; Embryonic brain kinase |
EPHA8 | EphA8 | Y | Eph | Wild-Type | EPH receptor A8 | EPHA8; EphA8; EPH receptor A8; EEK; EphA8; HEK3; KIAA1459; ephrin type-A receptor 8; EPH- and ELK-related kinase |
EPHB1 | EphB1 | Y | Eph | Wild-Type | EPH receptor B1 | EPHB1; EphB1; EPH receptor B1; ELK; NET; Hek6; EPHT2; HEK6; ephrin type-B receptor 1; CEK6; EPH-2; AW488255; EPB1; EPH2 |
EPHB2 | EphB2 | Y | Eph | Wild-Type | EPH receptor B2 | EPHB2; EphB2; EPH receptor B2; DRT; ERK; Hek5; EPHT3; Tyro5; CEK5; HEK5; ephrin type-B receptor 2; Ephrin type-B receptor 2; EPH3; EPH-3 |
EPHB3 | EphB3 | Y | Eph | Wild-Type | EPH receptor B3 | EPHB3; EphB3; EPH receptor B3; ETK2; HEK2; TYRO6; MDK5; SEK4; ephrin type-B receptor 3; Developmental kinase 5; CEK10; MDK-5; EPH receptor B3 |
EPHB4 | EphB4 | Y | Eph | Wild-Type | EPH receptor B4 | EPHB4; EphB4; EPH receptor B4; HTK; MYK1; TYRO11; ephrin type-B receptor 4; EPB4; Mdk2 |
MAPK3 (ERK1) | Erk1 | S/T | MAPKAPK | Wild-Type | Mitogen-activated protein kinase 3 | MAPK3; Erk1; Mitogen-activated protein kinase 3; p44erk1; p44mapk; PRKM3; MAPKAP3; Mitogen activated protein kinase activated protein kinase-3 |
MAPK1 (ERK2) | Erk2 | S/T | MAPK | Wild-Type | Mitogen-activated protein kinase 1 | MAPK1; Erk2; Mitogen-activated protein kinase 1; ERK; ERT1; MAPK2; P42MAPK; PRKM1; PRKM2; p38; p40; p41; p41mapk; MAP kinase 2; MAPK; Extracellular signal regulated kinase 2 |
MAPK7 (BMK, ERK5) | Erk5 | S/T | MAPK | Wild-Type | Mitogen-activated protein kinase 7 | MAPK7; Erk5; mitogen-activated protein kinase 7; extracellular-signal-regulated kinase 5; BMK1; PRKM7; BMK; ERK4; ERK-5 |
MAPK15 (ERK7) | Erk7 | S/T | MAPK | Wild-Type | Mitogen-activated protein kinase 15 | MAPK15; Erk7; mitogen-activated protein kinase 15; extracellular signal regulated kinase 8; ERK7; ERK8; BI916334; MK15; |
ERN1 (IRE1) | IRE1 | S/T | IRE | Wild-Type | Endoplasmic reticulum to nucleus signaling 1 | ERN1; IRE1; endoplasmic reticulum to nucleus signaling 1; inositol-requiring enzyme 1; ER to nucleus signalling 1; FLJ30999; IRE1P |
ERN2 (IRE2) | IRE2 | S/T | IRE | Wild-Type | Endoplasmic reticulum to nucleus signaling 2 | ERN2; IRE2; endoplasmic reticulum to nucleus signaling 2; ER to nucleus signalling 2; IRE1b; Inositol-requiring 2; hIRE2p; re1beta |
FAM20C | None | S/T | FAM20 | Wild-Type | FAM20C golgi associated secretory pathway kinase | FAM20C; family with sequence similarity 20, member C; golgi associated secretory pathway kinase; 4942737; DKFZp547D065; DMP4; G-CK; dentin matrix protein 4; golgi casein kinase |
FER | FER | Y | Fer | Wild-Type | Fer tyrosine kinase | FER; Fer tyrosine kinase; TYK3; fer; fps/fes related tyrosine kinase; AV082135; Phosphoprotein NCP94; C-FER; FERT2 |
FES | FES | Y | Fer | Wild-Type | FES proto-oncogene, tyrosine kinase | FES; FES proto-oncogene, tyrosine kinase; c-fes/fps protein; FPS; feline sarcoma oncogene; C-FES; Oncogene FES, feline sarcoma virus; FES/FPS |
FGFR1 | FGFR1 | Y | FGFR | Wild-Type | Fibroblast growth factor receptor 1 | FGFR1; Fibroblast growth factor receptor 1 ; BFGFR; CEK; fms-related tyrosine kinase 2; H2; H3; H4; H5; CEK; FLG; FLT2; KAL2; BFGFR; C- FGR; N-SAM; CD331; FGFBR; FGFR-1; Fgr; BFGF-R |
FGFR2 | FGFR2 | Y | FGFR | Wild-Type | Fibroblast growth factor receptor 2 | FGFR2; Fibroblast growth factor receptor 2; FGFR2; BEK; BFR-1; CD332; CEK3; CFD1; ECT1; FGFR-2; JWS; KGFR; KSAM; K-SAM; TK14; TK25; BFR1; craniofacial dysostosis 1; keratinocyte growth factor receptor |
FGFR3 | FGFR3 | Y | FGFR | Wild-Type | Fibroblast growth factor receptor 3 | FGFR3; Fibroblast growth factor receptor 3; CD333; CEK2; FGFR-3; HSFGFR3EX; JTK4; FGF-R3 wt; Heparin-binding growth factor receptor; SAM3; ACH; achondroplasia, thanatophoric dwarfism |
FGFR4 | FGFR4 | Y | FGFR | Wild-Type | Fibroblast growth factor receptor 4 | FGFR4; Fibroblast growth factor receptor 4; TKF; JTK2; MGC20292; CD334; MPK11 |
FGR | FGR | Y | Src | Wild-Type | FGR proto-oncogene, Src family tyrosine kinase | FGR; FGR proto-oncogene, Src family tyrosine kinase; SRC2; c-fgr; p55c-fgr; P55-FGR |
FLT1 (VEGFR1) | FLT1 | Y | VEGFR | Wild-Type | FMS-related tyrosine kinase 1 | FLT1; FMS-related tyrosine kinase 1; FLT; VEGFR1; vascular endothelial growth factor receptor 1; FRT; VGFR1; Flt-1 |
FLT3 | FLT3 | Y | PDGFR | Wild-Type | FMS-related tyrosine kinase 3 | FLT3; FLT3; FMS-related tyrosine kinase 3; FLK2; STK1; CD135; Fetal liver fms-related tyrosine kinase 3; FLT-3; Fetal liver kinase 2; FL cytokine receptor |
FLT4 (VEGFR3) | FLT4 | Y | VEGFR | Wild-Type | FMS-related tyrosine kinase 4 | FLT4; FMS-related tyrosine kinase 4; PCL; VEGFR3; Vascular endothelial growth factor receptor 3; VGR3 |
CSF1R (FMS) | FMS | Y | PDGFR | Wild-Type | Colony stimulating factor 1 receptor | CSF1R; FMS; Colony stimulating factor 1 receptor; C-FMS; CD115; CSFR; FIM2; CSFMR; Macrophage colony stimulating factor I receptor precursor; M-CSFR |
FRK | FRK | Y | Src | Wild-Type | Fyn related Src family tyrosine kinase | FRK; Fyn related Src family tyrosine kinase; GTK; PTK5; protein tyrosine kinase 5; RAK; Fyn-related kinase |
FYNa (FYN) | FYN | Y | Src | Wild-Type | FYN proto-oncogene, Src family tyrosine kinase | FYN; FYN proto-oncogene, Src family tyrosine kinase; MGC45350; SLK; SYN; p59-FYN; cFYN; FYN oncogene related to SRC, FGR, YES |
FYNb (FYN) | FYN | Y | Src | Wild-Type | FYN proto-oncogene, Src family tyrosine kinase | FYN; FYN proto-oncogene, Src family tyrosine kinase; MGC45350; SLK; SYN; p59-FYN; cFYN; FYN oncogene related to SRC, FGR, YES |
GAK | GAK | S/T | NAK | Wild-Type | cyclin G associated kinase | GAK; cyclin G associated kinase; auxilin-2; DNAJC26; MGC99654 |
MAP4K2 (GCK) | GCK | S/T | STE20 | Wild-Type | Mitogen-activated protein kinase kinase kinase kinase 2 | MAP4K2; GCK; Mitogen-activated protein kinase kinase kinase kinase 2; germinal center kinase; BL44; M4K2; RAB8IP; B lymphocyte serine/threonine-protein kinase; M4K2; MAPK/ERK kinase kinase kinase 2 |
EIF2AK4 (GCN2) | GCN2 | S/T | PEK | Wild-Type | Eukaryotic translation initiation factor 2 alpha kinase 4 | EIF2AK4; GCN2; eukaryotic translation initiation factor 2 alpha kinase 4; KIAA1338; E2AK4; GCN2-like protein; DKFZP434P061 |
MAP4K3 (GLK, KHS2) | KHS2 | S/T | STE20 | Wild-Type | Mitogen-activated protein kinase kinase kinase kinase 3 | MAP4K3; KHS2; Mitogen-activated protein kinase kinase kinase kinase 3; GLK; MAPKKKK3; RAB8IPL1; M4K3; germinal center kinase-like kinase; MAPK/ERK kinase kinase kinase 3; M4K3 |
GRK1 (RHOK) | RHOK | S/T | GRK | Wild-Type | G protein-coupled receptor kinase 1 | GRK1; RHOK; G protein-coupled receptor kinase 1; GPRK1; RK; Rhodopsin kinase |
GRK2 (ADRBK1, BARK1) | BARK1 | S/T | GRK | Wild-Type | G protein-coupled receptor kinase 2 | GRK2; G protein-coupled receptor kinase 2; ADRBK1; adrenergic, beta, receptor kinase 1; BARK1; GRK2; Beta-ARK-1; FLJ16718; ARBK1; BARK; Beta-adrenergic receptor kinase 1 |
GRK3 (ADRBK2, BARK2) | BARK2 | S/T | GRK | Wild-Type | G protein-coupled receptor kinase 3 | GRK3; BARK2; G protein-coupled receptor kinase 3; Adrenergic, beta, receptor kinase 2; ADRBK2; Beta-adrenergic receptor kinase 2; Beta-ARK-2 |
GRK4 (GPRK4) | GPRK4 | S/T | GRK | Wild-Type | G protein-coupled receptor kinase 4 | GRK4; GPRK4; G protein-coupled receptor kinase 4; G protein-coupled receptor kinase 2-like; GPRK2L; GRK4a; IT11 |
GRK5 (GPRK5) | GPRK5 | S/T | GRK | Wild-Type | G protein-coupled receptor kinase 5 | GRK5; GPRK5; G protein-coupled receptor kinase 5; GPRK5 |
GRK6 (GPRK6) | GPRK6 | S/T | GRK | Wild-Type | G protein-coupled receptor kinase 6 | GRK6; GPRK6; G protein-coupled receptor kinase 6; FLJ32135 |
GRK7 (GPRK7) | GPRK7 | S/T | GRK | Wild-Type | G protein-coupled receptor kinase 7 | GRK7; GPRK7; G protein-coupled receptor kinase 7; GPRK7 |
GSK3A (GSK3α) | GSK3A | S/T | GSK | Wild-Type | Glycogen synthase kinase 3 alpha | GSK3A; glycogen synthase kinase 3 alpha |
GSK3B (GSK3β) | GSK3B | S/T | GSK | Wild-Type | Glycogen synthase kinase 3 beta | GSK3B; glycogen synthase kinase 3 beta |
HASPIN | Haspin | S/T | Haspin | Wild-Type | Histone H3 associated protein kinase | HASPIN; histone H3 associated protein kinase; HASP; GSG2; germ cell associated 2; Germ cell-specific gene 2 protein; Haploid germ cell-specific nuclear protein kinase |
HCK | HCK | Y | Src | Wild-Type | HCK proto-oncogene, Src family tyrosine kinase | HCK; HCK proto-oncogene, Src family tyrosine kinase; hemopoietic cell kinase; JTK9; BMK; B-cell,myeloid kinase |
ERBB2 (HER2) | ErbB2 | Y | EGFR | Wild-Type | Erb-B2 Receptor Tyrosine Kinase 2 | ERBB2; HER2/ErbB2; Erb-B2 Receptor Tyrosine Kinase 2; neuro/glioblastoma derived oncogene homolog; NEU; NGL; HER2; TKR1; HER-2; CD340; epidermal growth factor receptor 2; MLN 19; C-erbB-2; Epidermal growth factor receptor-related protein |
ERBB4 (HER4) | ErbB4 | Y | EGFR | Wild-Type | Erb-B2 Receptor Tyrosine Kinase 4 | ERBB4; HER4/ErbB4; Erb-B2 Receptor Tyrosine Kinase 4; ALS19; HER4; human epidermal growth factor receptor 4; ErbB4 |
MAP4K4 (HGK, ZC1) | HGK | S/T | STE20 | Wild-Type | Mitogen-activated protein kinase kinase kinase kinase 4 | MAP4K4; ZC1/HGK; Mitogen-activated protein kinase kinase kinase kinase 4; hepatocyte progenitor kinase-like/germinal center kinase-like kinase; FLH21957; FLJ20373; HGK; KIAA0687; ZC1; NIK; HPK/GCK-like kinase; M4K4; MAPK kinase kinase kinase 4; MAPK/ERK kinase kinase kinase 4; MEK kinase kinase 4; MEKKK 4; Nck interacting kinase |
HIPK1 | HIPK1 | S/T | DYRK | Wild-Type | Homeodomain interacting protein kinase 1 | HIPK1; homeodomain interacting protein kinase 1; KIAA0630; MGC26642; MGC33446; MGC33548; Myak; Nbak2; HIK1 |
HIPK2 | HIPK2 | S/T | DYRK | Wild-Type | Homeodomain interacting protein kinase 2 | HIPK2; Homeodomain interacting protein kinase 2; PRO0593; STANK; Sialophorin tail associated nuclear serine,threonine kinase; Sialophorin tail associated nuclear serine/threonine kinase; NBAK1; Nuclear body associated kinase 1 |
HIPK3 | HIPK3 | S/T | DYRK | Wild-Type | Homeodomain interacting protein kinase 3 | HIPK3; homeodomain interacting protein kinase 3; ANPK; DYRK6; FIST; FIST3; PKY; YAK1; DJ8L15.1 |
HIPK4 | HIPK4 | S/T | DYRK | Wild-Type | Homeodomain interacting protein kinase 4 | HIPK4; homeodomain interacting protein kinase 4; FLJ32818; BG105231 |
MAP4K1 (HPK1) | HPK1 | S/T | STE20 | Wild-Type | Mitogen-activated protein kinase kinase kinase kinase 1 | MAP4K1; HPK1; Mitogen-activated protein kinase kinase kinase kinase 1; hematopoietic progenitor kinase 1; M4K1 |
EIF2AK1 (HRI) | HRI | S/T | PEK | Wild-Type | Eukaryotic translation initiation factor 2 alpha kinase 1 | EIF2AK1; HRI; eukaryotic translation initiation factor 2 alpha kinase 1; heme regulated initiation factor 2 alpha kinase; HRI; KIAA1369; EIF2AK-1; E2AK1; Hemin-sensitive initiation factor-2 alpha kinase; HCR; Heme-controlled repressor; heme-regulated inhibitor |
HUNK | HUNK | S/T | nan | Wild-Type | Protein-serine/threonine kinase | CAMK |
ICK | ICK | S/T | RCK | Wild-Type | Intestinal cell kinase | ICK; intestinal cell kinase; KIAA0936; MRK; MAK-related kinase; MGC46090; HICK; LCK2; Laryngeal cancer kinase 2; ECO |
IGF1R | IGF1R | Y | InsR | Wild-Type | Insulin-like growth factor 1 receptor | IGF1R; Insulin-like growth factor 1 receptor; CD221; IGFR; JTK13; MGC142170; MGC142172; MGC18216 |
CHUK (IKKA, IKKa) | IKKa | S/T | IkBKA | Wild-Type | Conserved helix-loop-helix ubiquitous kinase | CHUK; IKKa; conserved helix-loop-helix ubiquitous kinase; I-kappa-B kinase; IKK-alpha; inhibitor of nuclear factor kappa-B kinase subunit alpha; IKBKA; IKK1; IKKA; NFKBIKA; TCF16; I kappa-B kinase alpha |
IKKB (IKKβ) | IKKb | S/T | IKK | Wild-Type | Inhibitor of nuclear factor kappa-B kinase subunit beta | IKBKB; IKKb; Inhibitor of nuclear factor kappa-B kinase subunit epsilon; IKK2; IKKB; NFKBIKB; IKK-beta; inhibitor of kappa light polypeptide gene enhancer in B-cells, kinase beta; IKBKINASE; I-kappa-B kinase 2; I-kappa-B-kinase beta |
IKKE (IKKe) | IKKe | S/T | IKK | Wild-Type | Inhibitor of nuclear factor kappa-B kinase subunit epsilon | IKBKE; IKKe; Inhibitor of nuclear factor kappa-B kinase subunit epsilon; IKK-I; IKKE; KIAA0151; IKKI; I kappa-B kinase epsilon; IKKe; inhibitor of kappa light polypeptide gene enhancer in B-cells, kinase epsilon |
INSR (IR) | INSR | Y | InsR | Wild-Type | Insulin receptor | INSR; INSR; Insulin receptor; CD220; IR |
INSRR (IRR) | IRR | Y | InsR | Wild-Type | Insulin receptor-related receptor | INSRR; IRR; Insulin receptor-related receptor; insulin receptor-related protein; IR-related receptor |
IRAK1 | IRAK1 | S/T | IRAK | Wild-Type | Interleukin 1 receptor associated kinase 1 | IRAK1; interleukin 1 receptor associated kinase 1; IRAK; Pelle; MPLK; IL1RAK; IRAK-1 |
IRAK4 | IRAK4 | S/T | IRAK | Wild-Type | Interleukin 1 receptor associated kinase 4 | IRAK4; interleukin 1 receptor associated kinase 4; REN64; NY-REN-64; IRAK-4; IPD1 |
ITK | ITK | Y | Tec | Wild-Type | IL2-inducible T-cell kinase | ITK; IL2-inducible T-cell kinase; EMT 2; LYK 2; PSCTK2; TSK; T-cell-specific kinase; MGC126258; TLK; MGC126257 |
JAK1 [JH1] | JAK1 | Y | JakA | Wild-Type | Janus kinase 1 | JAK1; Janus kinase 1; JAK1A; JAK1B; JTK3 |
JAK1 [JH1-JH2] | JAK1_b | Y | JakA | Wild-Type | Janus kinase 1 | JAK1; Janus kinase 1; JAK1A; JAK1B; JTK3 |
JAK2 [JH1] | JAK2 | Y | JakA | Wild-Type | Janus kinase 2 | JAK2; Janus kinase 2; JTK10; AK-2 |
JAK2 [JH1-JH2] | JAK2_b | Y | JakA | Wild-Type | Janus kinase 2 | JAK2; Janus kinase 2; JTK10; AK-2 |
JAK3 [JH1] | JAK3 | Y | JakA | Wild-Type | Janus kinase 3 | JAK3; Janus kinase 3; JAKL; L-JAK; LJAK; leukocyte Janus kinase |
MAPK8 (JNK1) | JNK1 | S/T | MAPK | Wild-Type | Mitogen-activated protein kinase 8 | MAPK8; JNK1; mitogen-activated protein kinase 8; JUN N-terminal kinase; JNK; JNK1A2; JNK21B1/2; PRKM8; SAPK1; C-Jun N-terminal kinase 1; MK08; Stress-activated protein kinase JNK1; JNK1-alpha-2; JNK-46; JUN N-terminal kinase |
MAPK9 (JNK2) | JNK2 | S/T | MAPK | Wild-Type | Mitogen-activated protein kinase 9 | MAPK9; JNK2; mitogen-activated protein kinase 9; Jun kinase; JNK-55; JNK2A; JNK2B; PRKM9; p54a; SAPK; C-Jun N-terminal kinase 2; MK09; P54a; Stress-activated protein kinase; JNK2alpha; JNK2beta; JNK2-alpha-2 |
MAPK10 (JNK3) | JNK3 | S/T | MAPK | Wild-Type | Mitogen-activated protein kinase 10 | MAPK10; JNK3; mitogen-activated protein kinase 10; JNK3A; PRKM10; p493F12; FLJ12099; p54bSAPK; C-Jun N-terminal kinase 3; MK10; FLJ33785; Stress-activated protein kinase JNK3; JNK3-alpha-2 |
KDR (VEGFR2) | KDR | Y | VEGFR | Wild-Type | Kinase insert domain receptor | KDR; Kinase insert domain receptor; FLK1; fetal liver kinase 1; CD309; VEGFR; VEGFR2; vascular endothelial growth factor receptor 2; VGR2 |
MAP4K5 (KHS1) | KHS1 | S/T | STE20 | Wild-Type | Mitogen-activated protein kinase kinase kinase kinase 5 | MAP4K5; KHS1; Mitogen-activated protein kinase kinase kinase kinase 5; GCKR; MAPKKKK5; KHS; M4K5; Germinal center kinase-related |
KIT (SCFR, CD117) | KIT | Y | PDGFR | Wild-Type | KIT proto-oncogene receptor tyrosine kinase | KIT; SCFR; CD117; cKIT; c-Kit; PBT; piebald trait; v-kit Hardy-Zuckerman 4 feline sarcoma viral oncogene homolog; Mast/stem cell growth factor receptor |
LATS1 | LATS1 | S/T | NDR | Wild-Type | Large tumor suppressor kinase 1 | LATS1; large tumor suppressor kinase 1; WARTS; wts; LATS |
LATS2 | LATS2 | S/T | NDR | Wild-Type | Large tumor suppressor kinase 2 | LATS2; large tumor suppressor kinase 2; FLJ13161; LATS; KPM |
LCK | LCK | Y | Src | Wild-Type | LCK proto-oncogene, Src family tyrosine kinase | LCK; LCK proto-oncogene, Src family tyrosine kinase; LSK; lymphocyte-specific protein tyrosine kinase; p56lck; pp58lck; LSK-T; RP4-675E8.4 |
LIMK1 | LIMK1 | S/T | RAF | Wild-Type | LIM domain kinase 1 | LIMK1; LIM domain kinase 1; LIMK; KIZ; KIZ-1 |
LIMK2 | LIMK2 | S/T | RAF | Wild-Type | LIM domain kinase 2 | LIMK2; LIM domain kinase 1 |
STK11 (LKB1, AMPKK) | LKB1 | S/T | CAMKL | Wild-Type | Serine/threonine kinase 11 | STK11; LKB1; serine/threonine kinase 11; PJS; polarization-related protein; AMPKK; KPM; Renal carcinoma antigen NY-REN-19 |
STK10 (LOK) | LOK | S/T | STE20 | Wild-Type | Serine/threonine kinase 10 | STK10; LOK; serine/threonine kinase 10; lymphocyte-oriented kinase; PRO2729; GEK2 |
LRRK2 | LRRK2 | S/T | LRRK | Wild-Type | Leucine rich repeat kinase 2 | LRRK2; leucine rich repeat kinase 2; RIPK7; ROCO2; FLJ45829; DKFZp434H2111; PARK8; Parkinson disease 8; Dardarin |
LTK | LTK | Y | Alk | Wild-Type | Leukocyte receptor tyrosine kinase | LTK; Leukocyte receptor tyrosine kinase; TYK1; leukocyte tyrosine kinase |
LYNA (LYNa) | LYN | Y | Src | Wild-Type | LYN proto-oncogene, Src family tyrosine kinase | LYN; LYN proto-oncogene, Src family tyrosine kinase; JTK8; v-yes-1 Yamaguchi sarcoma viral related oncogene homolog; FLJ13161; FLJ26625; KPM |
LYNB (LYNb) | LYN | Y | Src | Wild-Type | LYN proto-oncogene, Src family tyrosine kinase | LYN; LYN proto-oncogene, Src family tyrosine kinase; JTK8; v-yes-1 Yamaguchi sarcoma viral related oncogene homolog; FLJ13161; FLJ26625; KPM |
MAK | MAK | S/T | Alpha | Wild-Type | Male germ cell associated kinase | MAK; male germ cell associated kinase; Muscle alpha-kinase; dJ417M14.2; RP62; Alpha-kinase 3; Muscle alpha-protein kinase; Alpha-protein kinase 3; ALPK3; KIAA1330; Midori |
MAP3K1 (MEKK1) | MAP3K1 | S/T | STE11 | Wild-Type | Mitogen-activated protein kinase kinase kinase 1 | MAP3K1; mitogen-activated protein kinase kinase kinase 1; MAPKKK1; MEKK; MEKK1; MEK kinase 1; M3K1; MAP3K1; MAPK/ERK kinase kinase 1 |
MAP3K10 (MLK2) | MLK2 | S/T | MLK | Wild-Type | Mitogen-activated protein kinase kinase kinase 10 | MAP3K10; MLK2; mitogen-activated protein kinase kinase kinase 10; mixed lineage kinase 2; MST; MST; MEKK10; MKN28 kinase; M3K10 |
MAP3K11 (MLK3) | MLK3 | S/T | MLK | Wild-Type | Mitogen-activated protein kinase kinase kinase 11 | MAP3K11; MLK3; mitogen-activated protein kinase kinase kinase 11; MGC17114; MLK- 3; PTK1; SPRK; MEKK11; Mixed lineage kinase 3; M3K11; MAPKKK11 |
MAP3K12 (DLK) | DLK | S/T | MLK | Wild-Type | Mitogen-activated protein kinase kinase kinase 12 | MAP3K12; DLK; mitogen-activated protein kinase kinase kinase 12; dual leucine zipper kinase DLK; MUK; ZPK; ZPKP1; MEKK12; M3K12 |
MAP3K13 (LZK) | LZK | S/T | nan | Wild-Type | Mitogen-activated protein kinase kinase kinase 13 | MAP3K13; LZK; mitogen-activated protein kinase kinase kinase 13 |
MAP3K14 (NIK) | NIK | S/T | STE-Unique | Wild-Type | Mitogen-activated protein kinase kinase kinase 14 | MAP3K14; NIK; mitogen-activated protein kinase kinase kinase 14; FTDCR1B; HS; HSNIK; MEKK14; M3K14 |
MAP3K2 (MEKK2) | MAP3K2 | S/T | STE11 | Wild-Type | Mitogen-activated protein kinase kinase kinase 2 | MAP3K2; mitogen-activated protein kinase kinase kinase 2; MAP/ERK kinase kinase 2; MAPKKK2; MEKK2B; MEKK2; MEK kinase 2; MEKK 2; M3K2; MAP3K2; |
MAP3K3 (MEKK3) | MAP3K3 | S/T | STE11 | Wild-Type | Mitogen-activated protein kinase kinase kinase 3 | MAP3K3; mitogen-activated protein kinase kinase kinase 3; MAP/ERK kinase kinase 3; MAPKKK3; MEK kinase3; MEKK3; M3K3; MAPK/ERK kinase kinase 3 |
MAP3K5 (ASK1) | MAP3K5 | S/T | STE11 | Wild-Type | Mitogen-activated protein kinase kinase kinase 5 | MAP3K5; mitogen-activated protein kinase kinase kinase 5; ASK1; apoptosis signal regulating kinase 1; MAPKKK5; MEKK5; MAPK/ERK kinase kinase 5; MEK kinase 5; M3K5 |
MAP3K6 (ASK2) | MAP3K6 | S/T | nan | Wild-Type | Mitogen-activated protein kinase kinase kinase 6 | MAP3K6; ASK2; mitogen-activated protein kinase kinase kinase 5 |
MAP3K7 (TAK1) | MAP3K7 | S/T | STE-Unique | Wild-Type | Mitogen-activated protein kinase kinase kinase 7 | MAP3K7; TAK1; mitogen-activated protein kinase kinase kinase 7; TGF-beta activated kinase 1; TGF1a; MEKK7; BA723P2.3 |
MAP3K8 (COT, Tpl2) | COT | S/T | STE-Unique | Wild-Type | Mitogen-activated protein kinase kinase kinase 8 | MAP3K8; COT; mitogen-activated protein kinase kinase kinase 8; c- COT; EST; ESTF; TPL2; Tpl-2; Tumor progression locus 2; MEKK8; FLJ10486; M3K8 |
MAP3K9 (MLK1) | MLK1 | S/T | MLK | Wild-Type | Mitogen-activated protein kinase kinase kinase 9 | MAP3K9; MLK1; Mitogen-activated protein kinase kinase kinase 9; MEKK9; PRKE1; mixed lineage kinase 1; M3K9; MAPKKK9 |
MARK1 | MARK1 | S/T | CAMKL | Wild-Type | Microtubule affinity regulating kinase 1 | MARK1; microtubule affinity regulating kinase 1; MARK; PAR-1C; KIAA1477; MAP/microtubule affinity-regulating kinase 1 |
MARK2 | MARK2 | S/T | CAMKL | Wild-Type | Microtubule affinity regulating kinase 2 | MARK2; Microtubule affinity-regulating kinase 2; PAR-1B; EMK1; ELKL motif kinase 1; MGC99619; PAR-1; Par1b; MAP/microtubule affinity-regulating kinase 2 |
MARK3 | MARK3 | S/T | CAMKL | Wild-Type | Microtubule affinity regulating kinase 3 | MARK3; Microtubule affinity-regulating kinase 3; MAP/microtubule affinity-regulating kinase 3; CTAK1; KP78; PAR1A; Cdc25C-associated protein kinase 1; Protein kinase STK10; ELKL2; ELKL motif kinase 2 |
MARK4 | MARK4 | S/T | CAMKL | Wild-Type | Microtubule affinity regulating kinase 4 | MARK4; microtubule affinity regulating kinase 4; FLJ90097; PAR-1D; MAP/microtubule affinity-regulating kinase 4; KIAA1860; MARKL1; Nbla0065 |
MAST3 | MAST3 | S/T | MAST | Wild-Type | Microtubule associated serine/threonine kinase 3 | MAST3; microtubule associated serine/threonine kinase 3; KIAA0561 |
MASTL | MASTL | S/T | MAST | Wild-Type | Microtubule associated serine/threonine kinase-like | MASTL; microtubule associated serine/threonine kinase-like; GWL; greatwall kinase homolog; THC2; FLJ14813; RP11- 85G18.2 |
MAP2K1 (MEK1) | MAP2K1 | S/T | STE7 | Wild-Type | Mitogen-activated protein kinase kinase 1 | MAP2K1; Mitogen-activated protein kinase kinase 1; MAPKK1; MKK1; PRKMK1; MEK1; ERK activator kinase 1; MAPK/ERK kinase 1; MAP kinase kinase 1; MAP2K1; Dual specificity mitogen-activated protein kinase kinase 1 |
MAP2K2 (MEK2) | MAP2K2 | S/T | STE7 | Wild-Type | Mitogen-activated protein kinase kinase 2 | MAP2K2; Mitogen-activated protein kinase kinase 2; MAPKK2; MKK2; PRKMK2; MEK2; ERK activator kinase 2; MP2K2; PRKMK2EC; MAP kinase kinase 2; MAP2K2; MAPK,ERK kinase 2; Dual specificity mitogen-activated protein kinase kinase 2 |
MAP2K3 (MEK3) | MAP2K3 | S/T | STE7 | Wild-Type | Mitogen-activated protein kinase kinase 3 | MAP2K3; mitogen-activated protein kinase kinase 3; dual specificity mitogen activated protein kinase kinase 3; MAP kinase kinase 3; MAPK/ERK kinase 3; MAPKK3; MEK3; MKK3; PRKMK3; MP2K3; MAPK/ERK kinase 3 |
MELK | MELK | S/T | CAMKL | Wild-Type | maternal embryonic leucine zipper kinase | MELK; maternal embryonic leucine zipper kinase; KIAA0175; PEg3 kinase; PK38 |
MERTK (MER) | MER | Y | Axl | Wild-Type | MER proto-oncogene, tyrosine kinase | MERTK; MER; MER proto-oncogene, tyrosine kinase; MER-PEN; RP38; c-MER; c-Eyk; Tyro12; MGC133349; MERK |
MET (c-MET, HGFR) | MET | Y | Met | Wild-Type | MET proto-oncogene, receptor tyrosine kinase | MET; MMET proto-oncogene, receptor tyrosine kinase; c-Met; HGFR; hepatocyte growth factor receptor; RCCP2; DFNB97 |
MINK1 (MAP4K6, MINK, ZC3) | MINK | S/T | STE20 | Wild-Type | Misshapen-like kinase 1 | MINK1; ZC3/MINK; Misshapen-like kinase 1; misshapen/NIK-related kinase; YSK2; B55; MAP4K6; MGC21111; MINK; ZC3; hMINKbeta; Z73/MINK |
MAPKAPK2 (MK2) | MAPKAPK2 | S/T | MAPKAPK | Wild-Type | Mitogen-activated protein kinase-activated protein kinase 2 | MAPKAPK2; Mitogen-activated protein kinase-activated protein kinase 2; MK2; MAPK2; MAP kinase-activated protein kinase 2; MAPK2; MAPKAP kinase 2; RPS6KC1 |
MAPKAPK3 (MK3) | MAPKAPK3 | S/T | MAPKAPK | Wild-Type | Mitogen-activated protein kinase-activated protein kinase 3 | MAPKAPK3; mitogen-activated protein kinase-activated protein kinase 3; 3PK; MAPKAP; MAPK3 |
MAPKAPK5 (MK5) | MAPKAPK5 | S/T | MAPKAPK | Wild-Type | Mitogen-activated protein kinase-activated protein kinase 5 | MAPKAPK5; mitogen-activated protein kinase-activated protein kinase 5; PRAK; MAP kinase-activated protein kinase 5; MAPKAP kinase 5 |
MYLK (smMLCK) | smMLCK | S/T | MLCK | Wild-Type | Myosin light chain kinase | MYLK; smMLCK; Myosin light chain kinase; KRP; MLCK; MLCK108; MLCK210; MLCK1; MYLK1; smooth muscle myosin light chain kinase; Myosin light chain kinase, smooth muscle and non-muscle isozymes; DKFZp686I10125; MSTP083; Telokin; FLJ12216; KRP |
MLK4 (MAP3K21) | MLK4 | S/T | STE-Unique | Wild-Type | Mitogen-activated protein kinase kinase kinase 21 | Mitogen-activated protein kinase kinase kinase 21; MAP3K21; MLK4 |
MNK1 | MNK1 | S/T | MAPKAPK | Wild-Type | MAP kinase interacting serine/threonine kinase 1 | MKNK1; MNK1; MAP kinase interacting serine/threonine kinase 1 |
MNK2 | MNK2 | S/T | MAPKAPK | Wild-Type | MAP kinase interacting serine/threonine kinase 2 | MKNK2; MNK2; MAP kinase interacting serine/threonine kinase 2; GPRK7; G protein-coupled receptor kinase 7; GPRK8 |
CDC42BPA (MRCKA) | MRCKa | S/T | DMPK | Wild-Type | CDC42 binding protein kinase alpha | CDC42BPA; MRCKa; CDC42 binding protein kinase alpha; FLJ23347; KIAA0451; myotonic dystrophy kinase-related Cdc42-binding kinase; PK428; MRCK-alpha; DMPK-like alpha; DKFZp686L1738 |
CDC42BPB (MRCKB) | MRCKb | S/T | nan | Wild-Type | CDC42 binding protein kinase beta | CDC42BPB; MRCKb; CDC42 binding protein kinase beta; KIAA1124; MRCK-beta; DMPK-like beta |
RPS6KA5 (MSK1) | MSK1 | S/T | RSK | Wild-Type | Ribosomal protein S6 kinase A5 | RPS6KA5; MSK1; ribosomal protein S6 kinase A5; MSPK1; RLPK; RSKL; MGC1911; Nuclear mitogen-and stress-activated protein kinase-1; Ribosomal protein S6 kinase; KS6A5 |
RPS6KA4 (MSK2) | MSK2 | S/T | RSK | Wild-Type | Ribosomal protein S6 kinase A4 | RPS6KA4; MSK2; ribosomal protein S6 kinase A4; RSK-B; KS6A4; Ribosomal protein kinase B |
SRPK3 (MSSK1) | MSSK1 | S/T | SRPK | Wild-Type | SRSF protein kinase 3 | SRPK3; MSSK1; SRSF protein kinase 3; SFRS protein kinase 3; STK23; serine/threonine kinase 23; MGC102944; MSSK1; Muscle-specific serine kinase 1 |
STK4 (MST1) | MST1 | S/T | STE20 | Wild-Type | Serine/threonine kinase 4 | STK4; MST1; Serine/threonine kinase 4; YSK3; yeast Ste20-like; DKFZp686A2068; KRS2; kinase responsive to stress 2; mammalian sterile 20-like 1; Krs-2 |
MST1R (RON) | RON | Y | Met | Wild-Type | Macrophage stimulating 1 receptor | MST1R; RON; Macrophage stimulating 1 receptor; CD136; CDw136; PTK8; c-met-related tyrosine kinase; MSP receptor; macrophage-stimulating protein receptor |
STK3 (CLIK1, MST2) | MST2 | S/T | STE22 | Wild-Type | Serine/threonine kinase 3 | STK3; MST2; Serine/threonine kinase 3; KRS1; FLJ90748; CLIK1; MESS1 |
STK24 (MST3) | MST3 | S/T | STE20 | Wild-Type | Serine/threonine kinase 24 | STK24; MST3; Serine/threonine kinase 24; MST-3; MST3B; STK3; STE20; STE20-like kinase 3; sterile 20-like kinase 3; RP11-111L24.5 |
STK26 (MST4) | MST4 | S/T | STE21 | Wild-Type | Serine/threonine kinase 26 | STK26; serine/threonine kinase 26; MASK; MST4; STE20-like kinase 4; RP6-213H19.1 |
mTOR (FRAP) | FRAP | S/T | PIKK | Wild-Type | Mechanistic target of rapamycin kinase | MTOR; FRAP; FRAP1; FRAP2; RAFT1; RAPT1; mechanistic target of rapamycin kinase; FK506 binding protein 12 (FKBP12)-rapamycin associated protein 1; dJ576K7.1; FLJ44809 |
MUSK | MUSK | Y | Musk | Wild-Type | Muscle associated receptor tyrosine kinase | MUSK; muscle associated receptor tyrosine kinase; muscle, skeletal, receptor tyrosine kinase; MGC126323; MGC126324 |
MYLK2 (skMLCK) | skMLCK | S/T | MLCK | Wild-Type | Myosin light chain kinase 2 | MYLK2; skMLCK; Myosin light chain kinase 2 ; KMLC; MLCK; MLCK2; myosin light chain kinase 2; skeletal muscle myosin light chain kinase; Myosin light chain kinase 2, skeletal/cardiac muscle |
MYLK3 (caMLCK) | caMLCK | S/T | MLCK | Wild-Type | Myosin light chain kinase 3 | MYLK3; caMLCK; myosin light chain kinase 3; MLC kinase; MLCK; MLCK2; MGC126319; MGC126320; Myosin light chain kinase 3 |
MYLK4 (SgK085) | SgK085 | S/T | MLCK | Wild-Type | Myosin light chain kinase family member 4 | MYLK4; SgK085; Myosin light chain kinase family member 4; FLJ00265; caMLCK like; LOC134927; NP_001012418; Sugen kinase 85 |
MYO3A | MYO3A | S/T | STE20 | Wild-Type | Myosin IIIA | MYO3A; myosin IIIA; DFNB30; deafness, autosomal recessive 30; Class III myosin; MY3A |
MYO3B | MYO3B | S/T | STE20 | Wild-Type | Myosin IIIB | MYO3B; myosin IIIB; MY3B; Myosin 3b |
STK38 (NDR1) | NDR1 | S/T | NDR | Wild-Type | Serine/threonine kinase 38 | STK38; NDR1; serine/threonine kinase 38; NDR; NDR-LSB; AA617404; DJ108K11.2 |
STK38L (NDR2) | NDR2 | S/T | NDR | Wild-Type | Serine/threonine kinase 38 like | STK38L; NDR2; serine/threonine kinase 38 like; nuclear Dbf2-related 2; KIAA0965; ST38L |
NEK1 | NEK1 | S/T | NEK | Wild-Type | NIMA related kinase 1 | NEK1; NIMA related kinase 1; KIAA1901; NY- REN-55; NIMA (never in mitosis gene a)-related kinase 1 |
NEK10 | NEK10 | S/T | nan | Wild-Type | NIMA related kinase 10 | NEK10; NIMA related kinase 10; NIMA (never in mitosis gene a)-related kinase 10 |
NEK11 | NEK11 | S/T | nan | Wild-Type | NIMA related kinase 11 | NEK11; NIMA related kinase 11; NIMA (never in mitosis gene a)-related kinase 11 |
NEK2 | NEK2 | S/T | NEK | Wild-Type | NIMA related kinase 2 | NEK2; NIMA related kinase 2; PPP1R111; protein phosphatase 1, regulatory subunit 111; RP67; NLK1; HsPK21; HNEK2A; NIMA (never in mitosis gene a)-related kinase 2; NEK2A |
NEK3 | NEK3 | S/T | NEK | Wild-Type | NIMA related kinase 3 | NEK3; NIMA related kinase 3; NIMA (never in mitosis gene a)-related kinase 3; HSPK36; MGC29949; glycogen synthase A kinase; hydroxyalkyl-protein kinase; phosphorylase B kinase kinase; NimA-related protein kinase 3 |
NEK4 | NEK4 | S/T | NEK | Wild-Type | NIMA related kinase 4 | NEK4; NIMA related kinase 4; NIMA (never in mitosis gene a)-related kinase 4; NRK2; serine/threonine kinase 2; STK2; pp12301 |
NEK5 | NEK5 | S/T | NEK | Wild-Type | NIMA related kinase 5 | NEK5; NIMA related kinase 5; NIMA (never in mitosis gene a)-related kinase 5; MGC75495 |
NEK6 | NEK6 | S/T | NEK | Wild-Type | NIMA related kinase 6 | NEK6; NIMA related kinase 6; NIMA (never in mitosis gene a)-related kinase 6; SID6-1512; NIMA |
NEK7 | NEK7 | S/T | NEK | Wild-Type | NIMA related kinase 7 | NEK7; NIMA related kinase 7; NIMA (never in mitosis gene a)-related kinase 7 |
NEK8 | NEK8 | S/T | nan | Wild-Type | NIMA related kinase 8 | NEK8; NIMA related kinase 8; NIMA (never in mitosis gene a)-related kinase 8 |
NEK9 | NEK9 | S/T | NEK | Wild-Type | NIMA related kinase 9 | NEK9; NIMA related kinase 9; DKFZp434D0935; MGC16714; NERCC; NERCC1; Nek8; KIAA1995; MGC138306 |
NIM1 (NIM1K) | NIM1 | S/T | CAMKL | Wild-Type | NIM1 serine/threonine protein kinase | NIM1; NIM1 serine/threonine protein kinase; MGC42105 |
NLK (LAK1) | NLK | S/T | MAPK | Wild-Type | Nemo like kinase | NLK; nemo like kinase; LAK1 |
NTRK1 (TRKA) | TRKA | Y | Trk | Wild-Type | Neurotrophic receptor tyrosine kinase 1 | NTRK1; TRKA; Neurotrophic receptor tyrosine kinase 1; MTC; TRK; TRK1; high affinity nerve growth factor receptor; tyrosine kinase receptor A; DKFZp781I14186 |
NTRK2 (TRKB) | TRKB | Y | Trk | Wild-Type | Neurotrophic receptor tyrosine kinase 2 | NTRK2; TRKB; Neurotrophic receptor tyrosine kinase 2; Trk-B; BDNF-NT-3 growth factors receptor |
NTRK3 (TRKC) | TRKC | Y | Trk | Wild-Type | Neurotrophic receptor tyrosine kinase 3 | NTRK3; TRKC; Neurotrophic receptor tyrosine kinase 3; Trk-C; GP145-TrkC; NT-3 growth factor receptor |
NUAK1 (ARK5) | NuaK1 | S/T | CAMKL | Wild-Type | NUAK1; NuaK1; NUAK family kinase 1; ARK5; AMP-activated protein kinase family member 5; KIAA0537; NUAK family, SNF1-like kinase 1 | NUAK1; NuaK1; NUAK family kinase 1; ARK5; AMP-activated protein kinase family member 5; KIAA0537; NUAK family, SNF1-like kinase, 1 |
NUAK2 (SNARK) | NuaK2 | S/T | CAMKL | Wild-Type | NUAK2; NuaK2; NUAK family kinase 2; FLJ90349; SNARK; SNF1/AMP activated protein kinase; DKFZp434J037; NUAK family, SNF1-like kinase 2 | NUAK2; NuaK2; NUAK family kinase 2; FLJ90349; SNARK; SNF1/AMP activated protein kinase; DKFZp434J037; NUAK family, SNF1-like kinase, 2 |
MAPK14 (p38a) | p38a | S/T | MAPK | Wild-Type | Mitogen-activated protein kinase 14 | MAPK14; p38a; mitogen-activated protein kinase 14; p38 MAP kinase; CSBP; CSBP1; CSBP2; EXIP; MXI2; Mxi2; PRKM14; PRKM15; RK; SAPK2A; p38; p38ALPHA; CRK1; CSAID binding protein; Cytokine suppressive anti-inflammatory drug binding protein |
MAPK11 (p38b) | p38b | S/T | MAPK | Wild-Type | Mitogen-activated protein kinase 11 | MAPK11; p38b; mitogen-activated protein kinase 11; P38BETA2; PRKM11; SAPK2; SAPK2B; p38-2; p38Beta; MARPK; MK11 |
MAPK13 (p38δ) | p38d | S/T | MAPK | Wild-Type | Mitogen-activated protein kinase 13 | MAPK13; p38d; Mitogen-activated protein kinase 13; PRKM13; SAPK4; p38delta; stress-activated protein kinase-4; p38 MAPK-delta; Mitogen-activated protein kinase p38 delta; MK13 |
MAPK12 (p38γ) | p38g | S/T | MAPK | Wild-Type | Mitogen-activated protein kinase 12 | MAPK12; p38g; Mitogen-activated protein kinase 12; ERK-6; ERK3; ERK5; ERK6; p38gamma; PRKM12; SAPK-3; SAPK3; extracellular signal-regulated kinase 6; stress-activated protein kinase-3 |
RPS6KB1 (p70S6K) | p70S6K | S/T | RSK | Wild-Type | Ribosomal protein S6 kinase, 70kDa, polypeptide 1 | RPS6KB1; p70S6K; Ribosomal protein S6 kinase, 70kDa, polypeptide 1; S6K1; STK14A; PS6K, p70 (S6K)-alpha; Ribosomal protein S6 kinase 1; KS6B1; S6K |
RPS6KB2 (p70S6KB) | p70S6Kb | S/T | RSK | Wild-Type | Ribosomal protein S6 kinase B2 | RPS6KB2; p70S6Kb; ribosomal protein S6 kinase B2; KLS; P70-BETA; P70-beta-1; P70-beta-2; S6K- beta2; S6K2; SRK; STK14B; p70 (S6K)-beta; S6 kinase-related kinase; KS6B2 |
PAK1 | PAK1 | S/T | STE20 | Wild-Type | p21 (RAC1) activated kinase 1 | PAK1; p21 (RAC1) activated kinase 1; PAKalpha; ADRB2; MUK2; P21 protein (Cdc42/Rac)-activated kinase 1 |
PAK2 | PAK2 | S/T | STE20 | Wild-Type | p21 (RAC1) activated kinase 2 | PAK2; p21 (RAC1) activated kinase 2; PAK65; PAKgamma; p21 (CDKN1A)-activated kinase 2; p21 protein (Cdc42/Rac)-activated kinase 2; S6/H4 kinase; C-t-PAK2; PAK 2; PAK-2 |
PAK3 | PAK3 | S/T | STE20 | Wild-Type | p21 (RAC1) activated kinase 3 | PAK3; p21 (RAC1) activated kinase 3; Beta-PAK; P65-PAK; PAKB; STK4; CDC42/RAC-effector kinase PAK-B; p21 (CDKN1A)-activated kinase 3; p21 protein (Cdc42/Rac)-activated kinase 3; PAK 3; PAK-3 |
PAK4 | PAK4 | S/T | STE20 | Wild-Type | p21 (RAC1) activated kinase 4 | PAK4; p21 (RAC1) activated kinase 4; p21 protein (Cdc42/Rac)-activated kinase 4; p21 (CDKN1A)-activated kinase 4; P21-activated kinase 4 |
PAK5 (PAK7) | PAK5 | S/T | STE20 | Wild-Type | p21 (RAC1) activated kinase 5 | PAK5; p21 (RAC1) activated kinase 5; PAK7; p21 (RAC1) activated kinase 7; p21 protein (Cdc42/Rac)-activated kinase 7; p21 (CDKN1A)-activated kinase 7; KIAA1264; MGC26232; P21-activated kinase 7 |
PAK6 | PAK6 | S/T | STE20 | Wild-Type | p21 (RAC1) activated kinase 6 | PAK6; p21 (RAC1) activated kinase 6; PAK5; p21 protein (Cdc42/Rac)-activated kinase 6; p21 (CDKN1A)-activated kinase 6 |
PASK | PASK | S/T | CAMKL | Wild-Type | PAS domain containing serine/threonine kinase | PASK; PAS domain containing serine/threonine kinase; DKFZP434O051; DKFZp686P2031; KIAA0135; PASKIN; STK3; STK37 |
PDGFRA (PDGFRα) | PDGFRa | Y | PDGFR | Wild-Type | Platelet derived growth factor receptor alpha | PDGFRA; PDGFRa; Platelet derived growth factor receptor alpha; PDGFR2; CD140a; GAS9; Alpha platelet-derived growth factor receptor; PDGFR-alpha; MGC74795 |
PDGFRB (PDGFRβ) | PDGFRb | Y | PDGFR | Wild-Type | Platelet derived growth factor receptor beta | PDGFRB; PDGFRb; Platelet derived growth factor receptor beta; PDGFR; JTK12; CD140B; PDGFR1; PDGFR-beta; Beta platelet-derived growth factor receptor |
PDK1 (PDHK1) | PDHK1 | S/T | PDHK | Wild-Type | Pyruvate dehydrogenase kinase isoform 1 | PDK1; PDHK1; pyruvate dehydrogenase kinase 1; PDPK1; PkB kinase; MGC20087; MGC35290; PRO0461 |
PDK2 (PDHK2) | PDHK2 | S/T | PDHK | Wild-Type | Pyruvate dehydrogenase kinase isoform 2 | PDK2; PDHK2; pyruvate dehydrogenase kinase isoform 2 |
PDK3 (PDHK3) | PDHK3 | S/T | PDHK | Wild-Type | Pyruvate dehydrogenase kinase isoform 3 | PDK3; PDHK3; pyruvate dehydrogenase kinase isoform 3 |
PDK4 (PDHK4) | PDHK4 | S/T | PDHK | Wild-Type | Pyruvate dehydrogenase kinase isoform 4 | PDK4; PDHK4; pyruvate dehydrogenase kinase isoform 4 |
PDPK1 (PDK1) | PDK1 | S/T | nan | Wild-Type | 3-phosphoinositide dependent protein kinase 1 | PI3K-activated kinase; PDK1; PkB kinase; MPDK1; PkB kinase; PkB-like; PkB-like 2; PRO0461; Protein kinase B kinase; EC 2.7.11.1; HPDK1; MGC20087; MGC35290 |
EIF2AK3 (PERK/PEK) | PEK | S/T | PEK | Wild-Type | Eukaryotic translation initiation factor 2 alpha kinase 3 | EIF2AK3; PEK; eukaryotic translation initiation factor 2 alpha kinase 3; DKFZp781H1925; PERK; WRS; E2AK3; Pancreatic eIF2-alpha kinase; PRKR-like endoplasmic reticulum kinase; HsPEK |
PRKG1 (PKG1, PGK) | PKG1 | S/T | PKG | Wild-Type | Protein kinase, cGMP-dependent, type I | PRKG1; PKG1; protein kinase, cGMP-dependent, type I; PRKGR1A; PRKGR1B; PRKG1, transcript variant 1; PRKG1, transcript variant 2; CGKI; MGC71944; PKG1a; PKG1b; PRKG1a; PRKG1b; cGKI-BETA; cGKI-alpha; KGP1A; PGK; PKG; PKG1-alpha; DKFZp686K042 |
PRKG2 (PKG2, PGK2, CGK2) | PKG2 | S/T | PKG | Wild-Type | Protein kinase, cGMP-dependent, type II | PRKG2; PKG2; protein kinase, cGMP-dependent, type II; PRKGR2; cGKII; cGMP-dependent protein kinase 2; KGP2 |
PHKG1 | PHKg1 | S/T | PHK | Wild-Type | Phosphorylase kinase catalytic subunit gamma 1 | PHKG1; PHKg1; phosphorylase kinase catalytic subunit gamma 1; PHKG; phosphorylase kinase, gamma 1 (muscle); KPBG |
PHKG2 | PHKg2 | S/T | PHK | Wild-Type | Phosphorylase kinase catalytic subunit gamma 2 | PHKG2; PHKg2; Phosphorylase kinase catalytic subunit gamma 2; GSD9C; KPBH; PHK gamma 2; phosphorylase kinase, gamma 2 (testis); PSK-C3 |
PIM1 | PIM1 | S/T | PIM | Wild-Type | Pim-1 proto-oncogene, serine/threonine kinase | PIM1; Pim-1 proto-oncogene, serine/threonine kinase; PIM |
PIM2 | PIM2 | S/T | PIM | Wild-Type | Pim-2 proto-oncogene, serine/threonine kinase | PIM2; Pim-2 proto-oncogene, serine/threonine kinase; Pim-2h |
PIM3 | PIM3 | S/T | PIM | Wild-Type | Pim-3 proto-oncogene, serine/threonine kinase | PIM3; Pim-3 proto-oncogene, serine/threonine kinase; Pim-2h |
PINK1 (PINK) | PINK1 | S/T | NKF2 | Wild-Type | PTEN induced putative kinase 1 | PINK1; PTEN induced putative kinase 1; BRPK; PARK6; Parkinson disease (autosomal recessive) 6 |
PRKACA (PKACA, PKACα) | PKACa | S/T | PKA | Wild-Type | Protein kinase cAMP-activated catalytic subunit alpha | PRKACA; PKACa; Protein kinase cAMP-activated catalytic subunit alpha; MGC48865; PKAC-alpha; PKACA; KAPCA; protein kinase A catalytic subunit alpha; protein kinase, cAMP-dependent, catalytic, alpha; cAMP-dependent protein kinase |
PRKACB (PKACB, PKACβ) | PKACb | S/T | PKA | Wild-Type | Protein kinase cAMP-activated catalytic subunit beta | PRKACB; PKACb; Protein kinase cAMP-activated catalytic subunit beta; protein kinase, cAMP-dependent, beta catalytic subunit; MGC41879; MGC9320; PKAC-beta; KAPCB; PKA C-beta; PKA-b; KAPB |
PRKACG (PKACG, PKACg) | PKACg | S/T | PKA | Wild-Type | Protein kinase cAMP-activated catalytic subunit gamma | PRKACG; PKACg; protein kinase cAMP-activated catalytic subunit gamma; protein kinase, cAMP-dependent, gamma catalytic subuni; KAPG; KAPCG; PKA C-gamma |
PRKCA (PKCα [alpha]) | PKCa | S/T | PKC | Wild-Type | Protein kinase C alpha | PRKCA; PKCa; Protein kinase C alpha; PKCA; PRKACA; PKC-alpha; KPCA; kinase PKC-alpha; PKC-alpha; PKC-A; Protein kinase C, alpha type; KPCA; MGC129900; MGC129901; |
PRKCB1 (PKCβ1 [beta1]) | PKCb | S/T | PKC | Wild-Type | Protein kinase C beta 1 | PRKCB; PKCb; Protein kinase C beta; PKCb; PKCB; PRKCB1; MGC41878; PKC-beta; KPCB; protein kinase C, beta |
PRKCB2 (PKCβ2 [beta2]) | PKCb | S/T | PKC | Wild-Type | Protein kinase C beta 2 | PRKCB; PKCb; Protein kinase C beta; PKCb; PKCB; PRKCB2; MGC41878; PKC-beta; KPCB; protein kinase C, beta |
PRKCD (PKCδ [delta]) | PKCd | S/T | PKC | Wild-Type | Protein kinase C delta | PRKCD; PKCd; Protein kinase C delta ; MAY1; MGC49908; nPKC-delta; KPCD; PKCD; PKC-delta; protein kinase C, delta; Protein kinase C, delta; KPCD; NPKC-delta |
PRKCE (PKCe [epsilon]) | PKCe | S/T | PKC | Wild-Type | Protein kinase C epsilon | PRKCE; PKCe; protein kinase C epsilon; PKCE; nPKC-epsilon; KPCE; PKC-epsilon; protein kinase C, epsilon; PKCEA; PRKC; MGC125656; MGC125657; NPKC-epsilon |
PRKCG (PKCγ [gamma]) | PKCg | S/T | PKC | Wild-Type | Protein kinase C gamma | PRKCG; PKCg; Protein kinase C gamma; PKCC; PKCG; SCA14; MGC57564; KPCG; PKC-gamma; protein kinase C, gamma; SCA14 |
PRKCH (PKCη [eta]) | PKCh | S/T | PKC | Wild-Type | Protein kinase C eta | PRKCH; PKCh; Protein kinase C eta; PKCL; PKC-L; PRKCL; MGC5363; MGC26269; nPKC-eta; KPCL; PKCH; protein kinase C, eta; NPKC-eta |
PRKCI (PKCι [iota]) | PKCi | S/T | PKC | Wild-Type | Protein kinase C iota | PRKCI; PKCi; Protein kinase C iota; PKCI; MGC26534; nPKC-iota; DXS1179E; PKCL; PRKCL; PKC iota; PKC lambda; protein kinase C, iota; APKC-lambda,iota; NPKC-iota; DXS1179E; HINT1; KPCI |
PRKCQ (PKCᶿ [theta]) | PKCt | S/T | PKC | Wild-Type | Protein kinase C theta | PRKCQ; PKCt; Protein kinase C theta; protein kinase C, theta; PRKCT; nPKC-theta; KPCT; PKCq; PKC-theta; MGC126514; MGC141919 |
PRKCZ (PKCζ [zeta]) | PKCz | S/T | PKC | Wild-Type | Protein kinase C zeta | PRKCZ; PKCz; Protein kinase C zeta; PKC2; KPCZ; PKCZ; PKC-ZETA; protein kinase C, zeta; NPKC-zeta |
PRKD1 (PKD1) | PKD1 | S/T | PKD | Wild-Type | Protein kinase D1 | PRKD1; PKD1; protein kinase D1; PRKCM; PKD; PKCM; PKC-MU; Protein kinase C, mu type; Protein kinase D; KPCD1; NPKC-mu |
PRKD2 (PKD2) | PKD2 | S/T | PKD | Wild-Type | Protein kinase D2 | PRKD2; PKD2; protein kinase D2; DKFZP586E0820; HSPC187; KPCO; NPKC-D2; KPCD2 |
PRKD3 (PKD3) | PKD3 | S/T | PKD | Wild-Type | Protein kinase D3 | PRKD2; PKD2; protein kinase D2; DKFZP586E0820; HSPC187; KPCO; NPKC-D2; KPCD2 |
PKN1 | PKN1 | S/T | PKN | Wild-Type | Protein kinase N1 | PKN1; protein kinase N1; PKN; DBK; MGC46204; PAK1; PKN; PRK1; PRKCL1; protein kinase C-like 1; Protease-activated kinase 1 |
PKN2 | PKN2 | S/T | PKN | Wild-Type | Protein kinase N2 | PKN2; protein kinase N2; PRKCL2; protein kinase C-like 2; PAK-2; cardiolipin-activated protein kinase Pak2; PRK2; STK7; PRO2042; MGC71074; MGC150606 |
PKN3 | PKN3 | S/T | PKN | Wild-Type | Protein kinase N3 | PKN3; protein kinase N3; PKNbeta; UTDP4-1; PKNbeta; RP11-545E17.1; PRKCL3 |
EIF2AK2 (PKR) | PKR | S/T | PEK | Wild-Type | Eukaryotic translation initiation factor 2 alpha kinase 2 | EIF2AK2; PKR; eukaryotic translation initiation factor 2 alpha kinase 2; interferon-inducible double stranded RNA dependent protein kinase; TIK |
PLK1 | PLK1 | S/T | PLK | Wild-Type | Polo like kinase 1 | PLK1; Polo like kinase 1; PLK; STPK13; ADRB2; PLK-1 |
PLK2 | PLK2 | S/T | PLK | Wild-Type | Polo like kinase 2 | PLK2; polo like kinase 2; SNK; serum-inducible kinase |
PLK3 | PLK3 | S/T | PLK | Wild-Type | Polo like kinase 3 | PLK3; polo like kinase 3; CNK; cytokine-inducible kinase; FNK; FGF-inducible kinase; PRK; Proliferation-related kinase |
PLK4 | PLK4 | S/T | PLK | Wild-Type | Polo like kinase 4 | PLK4; polo like kinase 4; SAK; STK18 |
PRKX | PRKX | S/T | PKA | Wild-Type | Protein kinase, X-linked | PRKX; protein kinase, X-linked; PKX1 |
PTK2 (FAK) | FAK | Y | Fak | Wild-Type | PTK2 protein tyrosine kinase 2 | PTK2; FAK; PTK2 protein tyrosine kinase 2; FADK; pp125FAK; FAK1; focal adhesion kinase 1; PPP1R71; protein phosphatase 1, regulatory subunit 71; FRNK |
PTK2B (PYK2) | PYK2 | Y | Fak | Wild-Type | Protein tyrosine kinase 2 beta | PTK2B; PYK2; Protein tyrosine kinase 2 beta; CADTK; Calcium-dependent tyrosine kinase; CAKB; Cell adhesion kinase beta; FADK2; FAK2; PTK; RAFTK; Related adhesion focal tyrosine kinase; CAK beta |
PTK6 (BRK) | BRK | Y | Src | Wild-Type | Protein tyrosine kinase 6 | PTK6; BRK; protein tyrosine kinase 6; Brk6 |
RAF1 [Y340E/Y341E] | RAF1 | S/T | RAF | Mutant | Raf-1 proto-oncogene, serine/threonine kinase | RAF1; Raf-1 proto-oncogene, serine/threonine kinase; c-RAF; CRAF; C-Raf proto-oncogene, serine/threonine kinase; Raf-1; v-raf-1 murine leukemia viral oncogene homolog 1 |
RET | RET | Y | Ret | Wild-Type | Ret proto-oncogene | RET; Ret proto-oncogene; RET51; rearranged during transfection; PTC; MTC1; HSCR1; Hirschsprung disease 1; MEN2A; MEN2B; multiple endocrine neoplasia and medullary thyroid carcinoma 1; CDHF12; CDHR16; cadherin-related family member 16; RET-ELE1; GDNF receptor; Glial cell line-derived neurotropic factor receptor |
RIPK1 | RIPK1 | S/T | RIPK | Wild-Type | Receptor interacting serine/threonine kinase 1 | RIPK1; receptor interacting serine/threonine kinase 1; RIP; RIK; receptor-interacting protein kinase 1; DCR2; TRAILR4; TRUNDD |
RIPK2 | RIPK2 | S/T | RIPK | Wild-Type | Receptor interacting serine/threonine kinase 2 | RIPK2; receptor interacting serine/threonine kinase 2; CARD3; CARDIAK; RICK; RIP2; RIP-like-interacting CLARP kinase; CARD-containing IL-1 beta ICE-kinase; GIG30 |
RIPK3 | RIPK3 | S/T | RIPK | Wild-Type | Receptor interacting serine/threonine kinase 3 | RIPK3; receptor interacting serine/threonine kinase 3; RIP3; receptor interacting protein 3 |
RIPK4 (ANKRD3) | ANKRD3 | S/T | RIPK | Wild-Type | receptor interacting serine/threonine kinase 4 | RIPK4; receptor interacting serine/threonine kinase 4; RIP4; ANKK2; ANKRD3; ankyrin repeat domain 3; DIK; PKK; PKC-delta-interacting protein kinase |
DSTYK (RIPK5, SGK496) | SGK496 | S/T | Other | Wild-Type | Dual serine/threonine and tyrosine protein kinase | DSTYK; SgK496; dual serine/threonine and tyrosine protein kinase; DustyPK, KIAA0472, RIP5; receptor interacting protein kinase 5; N11Rik; MGC4796; RP11- 268J15.4; SHIK HDCMD38P; RIP-homologous kinase; Dusty protein kinase |
ROCK1 | ROCK1 | S/T | DMPK | Wild-Type | Rho associated coiled-coil containing protein kinase 1 | ROCK1; Rho associated coiled-coil containing protein kinase 1; p160ROCK; p160-ROCK; ROK-beta; rho kinase; rho-associated protein kinase 1 |
ROCK2 | ROCK2 | S/T | DMPK | Wild-Type | Rho associated coiled-coil containing protein kinase 2 | ROCK2; Rho associated coiled-coil containing protein kinase 1; KIAA0619; ROC2; Rho-associated protein kinase 2; ROK-alpha; P164 ROCK-2 |
ROS1 (ROS) | ROS | Y | Sev | Wild-Type | ROS proto-oncogene 1, receptor tyrosine kinase | ROS1; ROS; ROS proto-oncogene 1, receptor tyrosine kinase; c-ros-1; c-ros oncogene 1, receptor tyrosine kinase; v-ros avian UR2 sarcoma virus oncogene homolog 1; MCF3; ROS; KROS |
RPS6KA1 (RSK1) | RSK1 | S/T | RSK | Wild-Type | Ribosomal protein S6 kinase A2 | RPS6KA2; RSK1; Ribosomal protein S6 kinase A2; HU-2; MAPKAPK1C; RSK; RSK3; Ribosomal protein S6 kinase alpha 1; S6K-alpha; S6K-alpha 2; KS6A2 |
RPS6KA3 (RSK2) | RSK2 | S/T | RSK | Wild-Type | Ribosomal protein S6 kinase A3 | RPS6KA3; RSK2; Ribosomal protein S6 kinase A3; HU-2; HU-3; MAPKAPK1B; MRX19; CLS; p90-RSK2; RSK; ISPK1; Insulin-stimulated protein kinase 1; KS6A3; MRX19; pp90RSK2; RPS6KA3; S6K-alpha 3 |
RPS6KA2 (RSK3) | RSK3 | S/T | RSK | Wild-Type | Ribosomal protein S6 kinase A1 | RPS6KA1; RSK3; Ribosomal protein S6 kinase A1; HU-1; MAPKAPK1A; p90Rsk; RSK; RSK1; S6K-alpha 1; KS6A1; KS6AA |
RPS6KA6 (RSK4) | RSK4 | S/T | RSK | Wild-Type | Ribosomal protein S6 kinase A6 | RPS6KA6; RSK4; ribosomal protein S6 kinase A6; Ribosomal S6 kinase 4; S6K-alpha 6; KS6A6 |
SBK1 (SBK) | SBK | S/T | NKF1 | Wild-Type | SH3 domain binding kinase 1 | SBK1; SBK; SH3 domain binding kinase 1; BG683070 |
SGK1 (SGK) | SGK1 | S/T | SGK | Wild-Type | Serum/glucocorticoid regulated kinase 1 | SGK1; SGK; Serum/glucocorticoid regulated kinase 1 |
SGK2 | SGK2 | S/T | SGK | Wild-Type | SGK2, serine/threonine kinase 2 | SGK2; SGK2, serine/threonine kinase 2; serum/glucocorticoid regulated kinase 2; dJ138B7.2 |
SGK3 | SGK3 | S/T | SGK | Wild-Type | Serum/glucocorticoid regulated kinase family member 3 | SGK3; Serum/glucocorticoid regulated kinase family member 3; CISK; SGK2; SGKL; serum/glucocorticoid regulated kinase-like |
SIK1 (SIK) | SIK | S/T | CAMKL | Wild-Type | Salt inducible kinase 1 | SIK1; SIK; salt inducible kinase 1; MSK; myocardial SNF1-like kinase; SNF1LK; SNF1-like kinase; SIK-1; SNF1LK; SN1L1 |
SIK2 (QIK) | QIK | S/T | CAMKL | Wild-Type | Salt inducible kinase 2 | SIK2; QIK; salt inducible kinase 2; SNF1LK2; SN1L2;SNF1-like kinase 2; DKFZp434K1115; KIAA0781; LOH11CR1I |
SIK3 (QSK) | QSK | S/T | CAMKL | Wild-Type | Salt inducible kinase 3 | SIK3; QSK; SIK family kinase 3; FLJ12240; KIAA0999; L19; SIK-3; Salt-inducible kinase 3 |
SLK | SLK | S/T | STE20 | Wild-Type | STE20 like kinase | SLK; STE20 like kinase; SNF1 sucrose nonfermenting like kinase (yeast); KIAA0204; STK2; bA16H23.1; se20- 9; CTCL tumor antigen se20-9; MGC133067 |
SNRK | SNRK | S/T | CAMKL | Wild-Type | SNF related kinase | SNRK; SNF related kinase; DKFZp779A1866; FLJ20224; HSNFRK; KIAA0096 |
SRC | SRC | Y | Src | Wild-Type | SRC proto-oncogene, non-receptor tyrosine kinase | SRC; SRC proto-oncogene, non-receptor tyrosine kinase; ASV; SRC1; c-SRC; p60-Src |
SRC N1 | SRC | Y | Src | Mutant | SRC; SRC proto-oncogene, non-receptor tyrosine kinase; ASV; SRC1; c-SRC; p60-Src | Protein-tyrosine kinase |
SRMS (SRM) | SRM | Y | Src | Wild-Type | SRC-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites; | SRMS; SRM; SRC-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites; PTK70; C20orf148; chromosome 20 open reading frame 148; dJ697K14.1 |
SRPK1 | SRPK1 | S/T | SRPK | Wild-Type | SRSF protein kinase 1 | SRSF protein kinase 1 |
SRPK2 | SRPK2 | S/T | SRPK | Wild-Type | SRSF protein kinase 2 | SRPK2; SRSF protein kinase 2; SFRSK2; serine/arginine-rich splicing factor kinase 2; SR protein kinase 2; SFRS protein kinase 2; FLJ36101 |
STK33 | STK33 | S/T | CAMK-Unique | Wild-Type | Serine/threonine kinase 33 | STK33; serine/threonine kinase 33 |
SYK | SYK | Y | Syk | Wild-Type | Spleen associated tyrosine kinase | SYK; Spleen associated tyrosine kinase; spleen tyrosine kinase; DKFZp313N1010; FLJ25043; FLJ37489; KSYK |
TAOK1 (TAO1) | TAO1 | S/T | STE20 | Wild-Type | TAO kinase 1 | TAOK1; TAO1; TAO kinase 1; FLJ14314; KIAA1361; MAP3K16; MARKK; PSK2; HKFC-B |
TAOK2 (TAO2) | TAO2 | S/T | STE20 | Wild-Type | TAO kinase 2 | TAOK2; TAO2; TAO kinase 2; KIAA0881; MAP3K17; TAO1; PSK; PSK1; Prostate-derived STE20-like kinase 1 |
TAOK3 (TAO3) | TAO3 | S/T | STE20 | Wild-Type | TAO kinase 3 | TAOK3; TAO3; TAO kinase 3; DKFZp666H245; DPK; JIK; MAP3K18 |
TBK1 | TBK1 | S/T | IKK | Wild-Type | TANK-binding kinase 1 | TBK1; TANK-binding kinase 1; CDC37; FLJ11330; HSPCA; HSPCB; IKBKG; T2K; TANK; TRAF2; NAK; NF-KB-activating kinase NAK |
TEC | TEC | Y | Tec | Wild-Type | Tec protein tyrosine kinase | TEC; Tec protein tyrosine kinase; PSCTK4; MGC126760; MGC126762 |
TEK (TIE2) | TIE2 | Y | Tie | Wild-Type | Tyrosine kinase with immunoglobulin like and EGF like domains 1 | TEK; TIE2; Tyrosine kinase with immunoglobulin like and EGF like domains 1; TEK tyrosine kinase, endothelial; CD202b; TIE-2; VMCM; VMCM1; venous malformations, multiple cutaneous and mucosal; Angiopoietin 1 receptor; HYK |
TESK2 | TESK2 | S/T | LISK | Wild-Type | Testicular protein kinase 2 | Dual specificity testis-specific protein kinase 2 |
TLK1 | TLK1 | S/T | TLK | Wild-Type | Tousled like kinase 1 | TLK1; tousled like kinase 1; PKU-beta; KIAA0137 |
TLK2 | TLK2 | S/T | TLK | Wild-Type | Tousled like kinase 2 | TLK2; TLK2; tousled like kinase 2; MGC44450; PKU-ALPHA |
TNIK (ZC2) | TNIK | S/T | STE20 | Wild-Type | TRAF2 and NCK interacting kinase | TNIK; ZC2/TNIK; TRAF2 and NCK interacting kinase; AD 2; KIAA0551; ZC2 |
TNK1 | TNK1 | Y | Ack | Wild-Type | Tyrosine kinase non receptor 1 | TNK1; tyrosine kinase non receptor 1; CD38 negative kinase 1 |
TNK2 (ACK) | ACK | Y | Ack | Wild-Type | Tyrosine kinase non receptor 2 | TNK2; ACK; tyrosine kinase non receptor 2; ACK1; p21cdc42Hs; Activated CDC42 kinase 1 |
PBK (TOPK) | PBK | S/T | TOPK | Wild-Type | PDZ binding kinase | PBK; PDZ binding kinase; CT84; cancer/testis antigen 84; TOPK; T-LAK cell-originated protein kinase; T-lymphokine-activated killer cell-originated protein kinase; SPK; Nori-3; FLJ14385; TOPK; NORI3 |
TSSK1B (TSSK1) | TSSK1 | S/T | TSSK | Wild-Type | Testis specific serine kinase 1B | TSSK1B; TSSK1; testis specific serine kinase 1B; STK22D; serine/threonine kinase 22D (spermiogenesis associated); FKSG81; SPOGA4; ST2A; STK22D; TSSK7P; SPOGA1 |
TSSK2 | TSSK2 | S/T | TSSK | Wild-Type | Testis specific serine kinase 2 | TSSK2; testis specific serine kinase 2; STK22B; serine/threonine kinase 22B (spermiogenesis associated); SPOGA2; FLJ38613; DGS-G; DGSG; DiGeorge syndrome protein G; ST2B; Testis-specific kinase 2 |
TSSK3 | TSSK3 | S/T | TSSK | Wild-Type | Testis specific serine kinase 3 | TSSK3; testis specific serine kinase 3; SPOGA3; STK22C; serine/threonine kinase 22C (spermiogenesis associated); ST2C |
TSSK6 (SSTK) | SSTK | S/T | TSSK | Wild-Type | Testis specific serine kinase 6 | TSSK6; SSTK; testis specific serine kinase 6; CT72; cancer/testis antigen 72; FLJ24002; TSSK4; FKSG82 |
TTBK1 | TTBK1 | S/T | TTBK | Wild-Type | Tau tubulin kinase 1 | TTBK1; tau tubulin kinase 1; KIAA1855; RP3- 330M21.4; BDTK |
TTBK2 | TTBK2 | S/T | TTBK | Wild-Type | Tau tubulin kinase 2 | TTBK2; tau tubulin kinase 2; KIAA0847; TTBK; SCA11; spinocerebellar ataxia 11 |
TTK | TTK | S/T | TTK | Wild-Type | TTK protein kinase | TTK; Threonine and Tyrosine kinase (TTK) protein kinase; CT96; cancer/testis antigen 96; MPH1, MPS1, MPS1L1; monopolar spindle 1 kinase; PYT; Phosphotyrosine picked threonine-protein kinase; ESK; Esk1; FLJ38280 |
TXK | TXK | Y | Tec | Wild-Type | TXK tyrosine kinase | TXK; TXK tyrosine kinase; BTKL; PSCTK5; PTK4; PTK4 protein tyrosine kinase 4; RLK; TKL; MGC22473 |
TYK2 [JH1] | TYK2 | Y | JakA | Wild-Type | Tyrosine kinase 2 | TYK2; Tyrosine kinase 2; JTK1 |
TYRO3 | TYRO3 | Y | Axl | Wild-Type | TYRO3 protein tyrosine kinase | TYRO3; TYRO3 protein tyrosine kinase; Etk-2; Rek; BYK; Brt; Dtk; Sky; Tif; RSE |
ULK1 | ULK1 | S/T | ULK | Wild-Type | Unc-51 like autophagy activating kinase 1 | ULK1; unc-51 like autophagy activating kinase 1; UNC51; Unc51.1; ATG1; ATG1A; ATG1 autophagy related 1 homolog; Unc-51-like kinase 1; FLJ38455 |
ULK2 | ULK2 | S/T | ULK | Wild-Type | Unc-51 like autophagy activating kinase 2 | ULK2; unc-51 like autophagy activating kinase 2; KIAA0623; Unc51.2; ATG1B; Unc-51-like kinase 2 |
ULK3 | ULK3 | S/T | ULK | Wild-Type | Unc-51 like autophagy activating kinase 3 | ULK3; unc-51 like autophagy activating kinase 3 |
VRK1 | VRK1 | S/T | VRK | Wild-Type | VRK serine/threonine kinase 1 | VRK1; vaccinia related kinase 1 |
VRK2 | CK1 | S/T | VRK | Wild-Type | VRK serine/threonine kinase 2 | VRK2; vaccinia related kinase 2 |
WEE1 | Wee1 | S/T | Yes | Wild-Type | Dual specificity protein kinase | Other |
YES1 (YES) | YES | Y | Src | Wild-Type | YES proto-oncogene 1, Src family tyrosine kinase | YES1; YES; YES proto-oncogene 1, Src family tyrosine kinase; C-YES; HsT441; P61-YES; v-yes-1 Yamaguchi sarcoma viral oncogene homolog 1 |
STK25 (YSK1) | YSK1 | S/T | STE20 | Wild-Type | Serine/threonine kinase 25 | STK25; YSK1; serine/threonine kinase 25; DKFZp686J1430; SOK1; YSK1; Ste20-like kinase; Sterile 20,oxidant stress-response kinase 1 |
MAP3K19 (YSK4) | MAP3K19 | S/T | STE11 | Wild-Type | Mitogen-activated protein kinase kinase kinase 19 | MAP3K19; mitogen-activated protein kinase kinase kinase 19; FLJ23074; MEKK19; RCK; regulated in COPD, protein kinase; YSK4; yeast Sps1/Ste20-related kinase 4; |
MAP3K20 (MLK7, ZAK) | ZAK | S/T | MLK | Wild-Type | Mitogen-activated protein kinase kinase kinase 20 | MEKK20; Mitogen-activated protein kinase kinase kinase MLT; Mixed lineage kinase-related kinase 7; MKKK20; MLK7; MLTK; MLTKalpha; MLTKbeta; MRK; mlklak; ZAK; |
ZAP70 | ZAP70 | Y | Syk | Wild-Type | Zeta-chain (TCR) associated protein kinase 70kDa | ZAP70; Zeta-chain (TCR) associated protein kinase 70kDa; SRK; Syk-related tyrosine kinase; STD; ZAP-70; TZK; ZA7 |